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Abstract 
The increasing prevalence of overweight and obesity is an alarming global issue. Not 
only do elevated body weights influence individual health and mortality, it also has an 
impact on a larger scale by placing financial burden on society. While diet-induced 
weight loss is the cornerstone treatment for overweight or obesity, some but not all 
studies have suggested that it has a harmful effect on bone and muscle strength. Bone 
and muscle strength are known in unison as the musculoskeletal system and have a 
parallel relationship, whereby factors affecting one system also tend to affect the 
other. Negative effects on bone and muscle strength independently, or together, 
results in an increased risk of disease states such as osteoporosis, dynaopenia and 
sarcopenia, and thus adversely affect overall health. The research presented in this 
thesis focuses on elucidating potential harmful implications that diet-induced weight 
loss may have on bone (Chapter 2) and muscle strength (Chapter 3), explored through 
two systematic reviews and meta-analyses using a random effects model.  
 
In Chapter 2, included data were from 41 publications of overweight or obese but 
otherwise healthy adults who followed a dietary weight loss intervention, and which 
examined total hip, lumbar spine or total body bone mineral density (BMD) via dual 
energy x-ray absorptiometry, or serum or urinary concentrations of markers of bone 
turnover, at the start and end of the intervention. There were significant decreases in 
total hip BMD with dietary interventions of 6, 12 or 24 (but not 3) months’ duration. 
No significant changes in BMD occurred in the lumbar spine or total body following 
dietary weight loss interventions ranging in duration from 3 to 24 months, except for a 
significant decrease in total body BMD after dietary interventions lasting 6 months. 
No significant changes occurred in the serum concentrations of the marker of bone 
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turnover, N-terminal propeptide of type I procollagen. Interventions of 2 or 3 months 
in duration (but not of 6, 12 or 24 months’ durations) induced significant increases in 
serum concentrations of the bone turnover markers osteocalcin, C-terminal 
telopeptide of type I collagen or N-terminal telopeptide of type I collagen, indicating 
an early effect of diet-induced weight loss to promote bone breakdown. While results 
from individual studies varies, this meta-analysis shows a clear effect of diet-induced 
weight loss to significantly reduce total hip BMD in overweight and obese 
individuals, consistent with the observed increases in circulating levels of bone 
turnover markers. Since the hip is the gold-standard site for diagnosing osteoporosis 
and assessing fracture risk, it is now important to determine the long-term effects that 
diet-induced weight loss may have on fracture risk in overweight and obese adults.  
 
In Chapter 3, the aim was to identify how diet-induced weight loss in adults with 
overweight or obesity impacts on muscle strength. 27 publications, including 33 
interventions, most of which were 8-24 weeks in duration, were included. Meta-
analysis of knee extensor strength as measured by isokinetic dynamometry found a 
significant decrease following diet-induced weight loss, by 7.5% from baseline 
values. Meta-analysis of handgrip strength showed a non-significant decrease with 
dietary restriction for weight loss. Due to variability in methodology and muscles 
tested, no other data could be meta-analyzed, and qualitative assessment of the 
remaining interventions revealed mixed results. Despite varying methodologies, diets 
and small sample sizes, these findings suggest a potential adverse effect of diet-
induced weight loss on muscle strength. While these findings should not act as a 
deterrent against weight loss in people with overweight or obesity, due to the known 
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health benefits of losing excess weight, they call for strategies to combat strength loss 
– such as weight training and other exercises – during diet-induced weight loss.  
 
From the two studies presented in this thesis, it can be seen that diet-induced weight 
loss can negatively impact on bone and muscle strength in overweight and obese 
populations. Bone and muscle are organs that are fundamental to the maintenance of 
health. They have a dual relationship whereby factors that affect one organ will also 
affect the other. This parallel regulation of bone and muscle was reflected in the 
findings from this thesis, where dietary weight loss interventions resulted in decreases 
in BMD, as well as reductions in muscle strength. Therefore weight loss can induce 
adverse effects, and this could conceivably increase the risk of problems such as 
osteoporosis and dynaopenia, but future research is needed to determine relative 
benefits, as well as the possible risks, of treating overweight and obesity with diet-
induced weight loss. Some of the mechanisms that may contribute to this dual 
detrimental effect of diet-induced weight loss on bone and muscle strength have been 
proposed in Chapter 4, however future research is necessary to determine the factors 
contributing to this potential adverse effect, as well as interventions to curb the 
possible negative consequences.  
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Chapter 1: General Introduction 
This chapter provides background on the health issue that is obesity, and how weight 
loss may impact aspects related to body composition, in particular, bone and muscle 
strength. Obesity has become an increasing dilemma in our society, not only having 
significant health impacts on an individual scale, but also placing a large financial 
burden at a population level (1, 2). Diet-induced weight loss is the first line of 
treatment to reduce the prevalence of obesity (3, 4), with it having positive influences 
in reducing the risk of mortality and co-morbidities (5). However, during energy 
deficit, the body undergoes physiological changes that have been eluded to have 
negative rather than positive effects on bone and muscle (6). The aim of this thesis 
was to investigate whether diet-induced weight loss results in deleterious effects on 
bone and muscle in overweight and obese populations. 
 
1.1 Definition of obesity  
Obesity is a state of excess adiposity or body fat. The cause of obesity is not singular 
but rather multifactorial, with influences such as physical inactivity, disordered 
eating, mental illness and genetics playing a role in this accumulation of excess body 
fat (5). Overweight and obesity are commonly classified by the body mass index 
(BMI), which takes into account the weight and height of an individual. BMI is 
calculated by dividing weight in kilograms (kg) by the height in meters (m) squared 
(kg/m2). A BMI of less than 18.5 kg/m2 is considered by the World Health 
Organization to be underweight, 18.5 to 24.9 kg/m2 is considered to be in the healthy 
and normal weight range, 25.0 to 29.9 kg/m2 is considered to be overweight, and a 
BMI greater or equal to 30.0 kg/m2 is considered clinically obese (7).  
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1.2 Prevalence and significance of obesity 
The prevalence of obesity worldwide is increasing yearly. A recent global analysis 
indicated that between 1980 and 2013, there was an increase in the number of 
overweight and obese individuals, from 857 million to 2.1 billion (8). The worldwide 
prevalence of overweight or obese males increased from 28.8% to 36.9% between 
1980 and 2013, whilst that of females rose from 29.8% to 38.2%. In Australia, results 
from the Australian Bureau of Statistics’ National Health Survey found that in 2011-
12, 62.8% of adults (aged 18 years and older) were classified as overweight or obese. 
Of these overweight or obese adults, 35.3% were categorized as being overweight. 
Furthermore the proportion of obese individuals grew from 18.7% to 27.5% between 
1995 and 2012 (9). Twenty-five percent of children in Australia in 2011-12 were 
overweight or obese (9). And so, overweight and obesity was the 2nd highest 
contributor to the burden of disease in Australia after dietary risks (9).  
 
Obesity has been identified as a risk factor for a number of co-morbidities including 
type-2 diabetes, cardiovascular diseases, musculoskeletal diseases, gallbladder 
diseases as well as cancers varying from kidney, colorectal and pancreatic to prostate, 
breast and ovarian, as highlighted in a recent meta-analysis (10). Moreover, obesity is 
associated with around 3.4 million deaths globally each year (8). These risk factors of 
obesity translate to health, economic and psychological consequences and in 2007-08, 
the total direct cost of overweight and obesity in Australia was $18.3 billion (2).  
 
1.3 Weight loss strategies  
Due to the multifaceted nature of obesity, various strategies to induce weight 
reduction have been developed. For example, dietary and/or physical activity 
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interventions, pharmacotherapy, and in cases of morbid obesity (for those with a BMI 
of 40 kg/m2 or greater) or severe obesity (35 kg/m2 or greater) with at least one 
obesity related comorbidity (11), bariatric surgery is often suggested.  
 
Dietary interventions are the cornerstone method of weight loss in overweight and 
obese individuals. Dietary interventions range from those severely restricting energy 
intake (very low energy diets; VLED) that induce large reductions in body weight, to 
moderately energy-restricted (MER) diets that often range in macronutrient 
composition and produce modest weight losses (12, 13). A VLED was defined as a 
diet providing less than 3.4 MJ per day (12, 14), and a MER was defined as a diet 
providing greater or equal to 5 MJ per day (13). In 2011-12, 13% of (or 2.3 million) 
Australians aged 15 years or older reported being on a diet for weight reduction or 
other health purposes (15). Furthermore, 17% (or 1.6 million) of the 9.2 million 
overweight or obese Australians were on a diet to induce weight loss in 2011-12 (15).  
 
Several pharmacological treatments have been developed and made available over 
time, however most do not have long-term efficacy and are often associated with 
adverse side effects and have thus been taken off the consumer market or not been 
approved by regulatory bodies. Currently pharmacotherapy options for overweight 
and obese individuals in Australia are limited, with only three approved drug 
treatments available for use to reduce body weight; orlistat, phentermine and – since 
December 2015 – liraglutide. Orlistat is an anti-obesity drug that acts by reducing 
dietary fat absorption by approximately 30% through gastric and pancreatic lipase 
inhibition, resulting in an approximate weight reduction of 2.9% after a one-year trial 
(16). However, side effects include fatty stools and diarrhoea which cause discomfort 
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in patients (16). The second drug available for purchase with a prescription in 
Australia is phentermine, which acts to suppress appetite, yet like orlistat also has 
short term side effects, in this case dry mouth, insomnia and cardiovascular 
complications, for example (17). Lastly, liraglutide, a newly developed weight loss 
drug marketed as Saxenda, acts as an analogue of glucagon like peptide 1, which 
causes a reduction in hunger levels and thus indirectly decreases energy intake, 
leading to the desired outcome of weight loss (18). This dose of liraglutide however is 
not to be confused with another dose formulation of liraglutide, which is used for the 
management of type-2 diabetes and is marketed as Victoza. The long-term effects of 
liraglutide as used for weight loss are limited, with only one-year clinical trials having 
thus far been conducted (19, 20). However, short term side effects of liraglutide for 
weight loss include an increase in heart rate and dehydration (18). Importantly, it 
should be noted that with all pharmacological interventions for obesity, concomitant 
lifestyle modification is recommended. 
 
In those individuals with a BMI ≥ 40 kg/m2, or those with a BMI ≥ 35 kg/m2 and with 
at least one obesity-related comorbidity, bariatric surgery is the most effective 
treatment option. Bariatric surgery induces reductions in body weight that are 
maintained in the long term for the majority of patients, with weight losses of around 
15 – 40% being achieved and maintained for a minimum of 10 years post surgery, 
depending on the particular surgical procedure (21). The three most common surgical 
interventions are Roux-en Y gastric bypass, sleeve gastrectomy and laprascopic 
adjustable gastric banding. These interventions, although differing in the mechanism 
via which energy intake is reduced, have been proven to be successful and as a 
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consequence, a greater number of obese individuals are seeking surgical intervention 
in conjunction with lifestyle modifications to reduce body weight (22, 23).  
 
The above-mentioned methods of weight reduction vary in both procedure and 
efficiency. However, with any weight loss intervention, dietary modification is at its 
core, with various positive outcomes of diet-induced weight loss having been well 
established (24). These include reductions in cardiovascular disease risk (25), 
hypertension (26), lipid profile (27) and inflammation  (28). Until recently, any 
hazardous side effects of diet-induced weight loss have been largely ignored, with the 
aforementioned benefits of weight loss outweighing the risks. The potential adverse 
effects of energy-restriction are related to changes in hormones, such as those 
regulated by the hypothalamic-pituitary axes. Studies have shown that in both lean 
animals and in overweight or obese humans an inhibition of the gonadotropic (29, 30) 
and somatotropic axes occurs (31, 32). Inhibition of these systems results in down-
stream consequences. For example, reductions in circulating concentrations of sex 
steroids and insulin like growth factor 1 (IGF-1), may decrease bone mineral density 
(6, 33, 34) and muscle strength (6, 35). Therefore, there is a need for any potential 
negative repercussions of diet-induced weight loss to be explored in order to then 
identify measures to counteract or minimize these changes. The aims of this thesis 
were to examine the effect of weight loss through dietary intervention on bone and 
muscle strength in overweight and obese individuals.  
 
1.4 Bone 
The skeletal system plays a pivotal role in the body providing structural, functional 
and biochemical support to other organs and cells of the body. Furthermore, from a 
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clinical perspective, bone, more specifically bone mineral density (BMD), is 
extremely important due to its association with osteoporosis, incidence of falls and 
fractures that in turn result in an increased risk of mortality (36-38). Therefore, it is 
crucial that bone integrity is maintained. In the following section, bone composition 
and methods of assessing bone integrity are explored. 
 
1.4.1 Bone Composition 
Bone is a specialized connective tissue composed of both organic matter (type I 
collagen, growth factors, blood proteins, osteonectin, osteocalcin) as well as inorganic 
matter (mineral hydroxyapatite (Ca10(PO4)6(OH)2) (39, 40). Histologically, there are 
two principle forms of mature bone; cortical and trabecular bone. Cortical bone makes 
up around 80% of the skeleton, covering the outer surface of bones (41).  Cortical 
bone has a high density due to the organization of bone tissue in concentric sheets or 
lamellae with a central canal containing neurovascular bundles (41, 42). As a result of 
its highly and tightly organised structure, cortical bone provides resistance to uniaxial 
stresses (41, 43). Contrastingly, trabecular bone is found in areas exposed to high 
stress, such as the vertebrae and hip, and is essential for the strength and integrity of 
bone because of its ability to absorb large mechanical loads (41). The mechanical 
property of trabecular bone is a consequence of the lamellae having a less compact 
structure than cortical bone, forming an interconnecting meshwork of trabeculae that 
form spaces filled with bone marrow, ultimately producing a large surface area of 
bone (35, 41, 42).  
 
Bone undergoes constant remodeling, which is a tightly coupled balance of bone 
formation and resorption, through the degradation of bone via osteoclastic cells, and 
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the laying down of bone by osteoblastic cells (41). Bone remodeling helps to uphold 
the integrity of bone by repairing ischemic or micro-fractures. It is also important for 
maintaining calcium homeostasis, and for adjusting and strengthening bone 
architecture in response to various mechanical loads and strains inflicted on it (44, 
45).  
 
1.5 Methods of assessing bone integrity  
Bone integrity can be defined as the size of bone, shape, micro-architecture, density 
and quality of bone (46). Two main techniques are used in the assessment of bone 
integrity. Clinically, dual energy x-ray absorptiometry (DXA) is the gold-standard 
technique for the determination of BMD. In contrast, bone turnover – the osteoblastic-
osteoclastic homeostatic cycle, can be examined through the concentration of bone 
turnover markers measured in either serum or urine. There are distinct markers for 
bone formation or bone resorption and as such, they aid in the determination of the 
rate at which bone is remodeled, as well as whether formation or resorption is 
favoured (42). The methods used for the determination of BMD as well as changes in 
bone turnover, will be described in detail in the next sections.  
 
1.5.1 Assessing bone integrity with DXA  
DXA is a method used for the quantification of BMD, which can provide an overall 
picture of the integrity of bone. DXA is based on a beam of radiation that is targeted 
at a radiation detector below a table upon which a patient lies. The beam of radiation 
then moves relative to the table so that the body is scanned. The weakened radiation 
ray is then correlated to BMD (47, 48).  
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DXA measurements of BMD are important in clinical practice, having both a 
diagnostic and prognostic role (49) and is the primary technology used for the 
determination of osteoporosis and calculation of risk of falls and fractures (50, 51). 
However, it should be noted that artifacts might occur, particularly in individuals who 
are overweight or obese and in those who are undergoing weight changes. Indeed, the 
accuracy and precision of DXA is known to decrease with increasing BMI (52). This 
is a consequence of various factors including difficulties in accurately positioning 
obese patients onto the scanning bed, as well as excess adipose tissue causing 
measurement errors. One study illustrated the influence of excess fat by layering 
plastic bags filled with fat around phantom spine models and healthy, non-obese 
humans (52). When fat was positioned around the phantom spine model, an increase 
in BMD was detected by DXA, in contrast to the decrease in spine BMD that was 
registered by DXA when fat was layered around the torso of 13 healthy human 
volunteers (≤ 30 kg/m2) (52). Moreover, DXA results are compromised when 
participants undergo changes in body weight, as this affects the precision of DXA 
(53-55). This is related to a technical limitation of DXA, in that its dual energy x-ray 
sources can only measure two tissue types at any one time (e.g. bone and soft tissue). 
Thus, being a two-compartment model for the determination of body composition, 
DXA calculations assume certain ratios of fat to lean tissues in order to calculate the 
density of bone tissue as well as fat mass and fat free mass (42). However, these 
assumed ratios may be violated in obesity and with weight changes (e.g. after weight 
loss) (56). Lastly, BMD as determined by DXA is only able to detect changes in bone 
turnover 6-12 months after the initiation of an intervention (42). In light of these 
limitations in the use of DXA to assess bone, particularly during weight loss 
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interventions in overweight or obese individuals, other forms of bone assessment, 
such as measurement of bone turnover markers, should be employed.  
 
 
 
1.5.2 Bone turnover markers 
The importance of bone turnover markers in assessing changes occurring in bone has 
become increasingly important due to the aforementioned technical limitations of 
DXA, particularly in overweight or obese people undergoing changes in body mass. 
In contrast to DXA, bone turnover markers are able to reveal changes in bone 
physiology 2-3 months after commencement of various treatments, such as diet 
induced weight loss or medications (57). Moreover, bone turnover markers may 
predict fracture risk (58) and are able to elucidate whether increases or decreases 
occur in markers of bone formation and markers of bone resorption. Markers of bone 
formation include N-terminal propeptide of type I collagen (P1NP) and osteocalcin. 
On the other hand, markers of bone resorption are C- terminal telopeptide of type I 
collagen (CTX) and N-terminal telopeptide of type I collagen (NTX). These bone 
turnover markers will be discussed in this thesis, and were chosen due to international 
recommendations and associations with detecting changes in bone homeostasis (42).  
 
As mentioned above, bone formation involves the deposition of new bone matrix by 
osteoblast cells. P1NP is a bone formation marker that is a cleavage product of type I 
procollagen found in bone matrix (42). Type I procollagen is enzymatically broken 
down by N-procollagenase, which is secreted by osteoblasts,, and P1NP can be found 
circulating in blood as a by-product during bone formation (42). The International 
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Osteoporosis Federation and the International Federation of Clinical Chemistry and 
Laboratory Medicine recently recommended that serum concentrations of P1NP be 
measured as a marker of bone formation for clinical practice and research (58-61). 
Another marker of bone formation is osteocalcin, a 49 amino acid peptide produced 
directly from osteoblasts during bone formation, which thus has a high specificity for 
indicating osteoblastic activity (62). Recent evidence from a study of older men 
highlighted that osteocalcin has a high predictive ability in the determination of 
fracture risk and incidence of hip fracture compared to other markers such as P1NP 
(63). Hence, both these markers of bone formation; P1NP and osteocalcin, should be 
measured to determine bone turnover (63), and were included in this thesis. 
 
Osteoclasts are lytic cells that degrade the bone matrix through secretion of enzymes 
and proteases. During bone resorption, osteoclasts hydrolyze type I collagen (58). 
CTX and NTX are two breakdown products of type I collagen from the bone matrix, 
which can be detected in both serum and urine. These markers of bone resorption are 
known to be specific and sensitive in detecting bone resorption (62), however their 
concentrations are known to vary with circadian rhythms (64). The International 
Osteoporosis Federation and the International Federation of Clinical Chemistry and 
Laboratory Medicine recommend that serum CTX be measured as a marker of bone 
resorption (58), because over a time period CTX levels remain more stable in 
circulation in comparison to other markers of bone resorption (65, 66). In addition to 
CTX, serum or urinary concentrations of NTX has been measured in a large number 
of studies and has been shown to be an effective marker in assessing the efficacy of 
osteoporosis treatment (67). Therefore, it is important that both markers of bone 
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resorption, CTX and NTX, are analysed in assessing bone, and were thus both 
included in this thesis. 
 
 
 
 
1.6 Muscle  
Muscle and bone are together commonly referred to as the musculoskeletal system 
due to their inherent interrelated properties and their shared mesenchymal tissue 
origin as well as parallel changes that occur in both over time with exercise, disuse or 
age (68). Therefore, if an analysis of bone integrity is undertaken, muscle too should 
also be examined. Muscle function plays a fundamental role in determining the level 
of exercise performance, the ease of activities of daily living, and frailty (69). 
However, diet-induced weight loss may, through changes in hormonal levels and 
physiological adaptations, cause negative changes in muscle mass and function, 
including strength (6). Muscle function can also be influenced by the degree of stretch 
of the muscle, contraction velocity, the specific fibre types within the muscle as well 
as the level of muscle fiber recruitment (70). The following section describes muscle 
strength and the forms of assessment used to determine muscle strength.  
 
1.6.1 Muscle strength  
Muscle strength can be predicted by fat free mass (71, 72), often referred to as lean 
body mass, and fat free mass is associated with muscle mass (73). Muscle strength is 
defined as the ability of a muscle to generate maximal force (74, 75). Muscle strength 
has been correlated to several health outcomes and is a highly regarded clinical 
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indictor of an individual’s functional capacity, as well as providing an insight into the 
mass and quality of muscle (76). Age impacts muscle strength, with reductions of 8 – 
10% occurring every decade after the age of 40 years (74), and this is related to the 
disease state known as dynaopenia (71). Another noteworthy muscular disease state 
related to advancing age is sacropenia, an age related decline in muscle mass (71, 77). 
Dynaopenia and sacropenia both relate to poor prognostic outcomes (78, 79) and thus, 
methods of maintaining and strengthening muscle is an important avenue for the 
maintenance of optimum health.  
 
1.6.2 Muscle strength assessments  
Muscle strength is typically assessed through muscular contraction, with the form of 
contraction varying depending on the technique. There are several methods in use for 
measuring muscle strength, depending on which groups of muscles are to be 
examined. The four commonly applied methods of muscle strength testing that will be 
discussed in this thesis are one repetition maximum (1RM) strength testing, isokinetic 
dynamometry, isometric dynamometry and handgrip strength testing (a form of 
isometric dynamometry).  
 
The multiple methods of assessing muscle strength vary in their ability to detect 
changes in strength, even when the same muscles are investigated. This was shown in 
a study that investigated three different modes of muscle strength assessment (1RM, 
isokinetic dynamometry and isometric dynamometry) in the forearm / elbow 
extensors in men undergoing a 12-week resistance-training program (80). This study 
found that the degree of increase in muscle strength varied according to the method 
used to assess it. Strength was found to increase by the greatest extent when the 1RM 
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procedure was undertaken, followed by isokinetic dynamometry and lastly, with the 
least force difference from baseline detected, isometric dynamometry (80). This 
finding highlights the need to cross-examine different muscle strength assessments 
and to develop a uniform mode of assessment in order to compare intervention validly 
and reliably.  
 
Handgrip strength has been found to be a marker of nutritional status (81, 82), as well 
as being a predictor of health outcomes (82, 83). For example, reviews highlight that 
low handgrip strength is associated with a greater number of post-surgical 
complications, including loss of physical functionality and longer hospitalization (82, 
84). Such correlations between handgrip strength and health give clinical importance 
to this particular strength test. Moreover, due to the flexibility and ease of obtaining 
handgrip strength measurements, handgrip strength findings were included in this 
thesis. 
 
1.7 Aims of the study 
Given the importance of bone and muscle strength to long-term health, the aims of 
this thesis were to examine the effect of diet-induced weight loss on bone and muscle 
strength in overweight and obese populations. More specifically, the first study 
(Chapter 2) aimed to quantify the changes in BMD and bone turnover markers in 
order to establish the effect of diet-induced weight loss on bone. This was achieved 
through the collation of literature in the form of a systematic review and quantified 
through meta-analysis. The purpose of the second study in this thesis (Chapter 3) was 
to reveal the impact of diet-induced weight loss on muscle strength, as well as to 
clarify and identify suitable methods of assessing muscle strength. To achieve this, 
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literature was searched systematically and data extracted and meta-analyzed so that 
the effects of diet-induced weight loss on muscle strength could be highlighted and 
quantified. Meta-analysis studies are placed at the top of the hierarchy of evidence, 
and, systematic reviews and randomized control studies are placed underneath. Meta-
analyses provide quantitative data from all studies investigating the same effect, by 
collating all data sets resulting in a single outcome value (85).  
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Chapter 2: Does diet-induced weight loss lead to bone loss in 
overweight or obese adults? A systematic review and meta-analysis of 
clinical trials 
 
Published in 2015 Journal of Bone and Mineral Research, vol. 30, no. 12, pp. 2168-2178 
 
2.1 Abstract  
Diet-induced weight loss has been suggested to be harmful to bone health. We conducted a 
systematic review and meta-analysis (using a random-effects model) to quantify the effect of diet-
induced weight loss on bone. We included 41 publications involving overweight or obese but 
otherwise healthy adults who followed a dietary weight loss intervention. The primary outcomes 
examined were changes from baseline in total hip, lumbar spine and total body BMD, as assessed 
by dual energy X-ray absorptiometry. Secondary outcomes were markers of bone turnover. Diet-
induced weight loss was associated with significant decreases of 0.010-0.015 g/cm2 in total hip 
BMD for interventions of 6, 12 or 24 (but not 3) months’ duration ([95% confidence intervals] [-
0.014 to -0.005], [-0.021 to -0.008], and [-0.024 to -0.000] g/cm2 at 6, 12 and 24 months, 
respectively). There was however no statistically significant effect of diet-induced weight loss on 
lumbar spine or whole body BMD for interventions of 3 to 24 months’ duration, except for a 
significant decrease in total body BMD (-0.011 [-0.018 to -0.003] g/cm2) after 6 months. While no 
statistically significant changes occurred in serum concentrations of N-terminal propeptide of type I 
procollagen (P1NP), interventions of 2 or 3 months in duration (but not of 6, 12 or 24 months’ 
durations) induced significant increases in serum concentrations of osteocalcin (0.26 [0.13-0.39] 
nmol/L), C-terminal telopeptide of type I collagen (CTX, 4.72 [2.12-7.30] nmol/L) or N-terminal 
telopeptide of type I collagen (NTX, 3.70 [0.90-6.50] nmol/L bone collagen equivalents [BCE]), 
indicating an early effect of diet-induced weight loss to promote bone breakdown. These data show 
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that in overweight and obese individuals, a single diet-induced weight loss intervention induces a 
small decrease in total hip BMD, but not lumbar spine BMD. This decrease is small in comparison 
to known metabolic benefits of losing excess weight.  
 
2.2 Introduction 
Osteoporosis and its consequence of fragility fracture represent a significant burden on public 
health. Up to 38% of women and 8% of men aged 50 years and above are affected by osteoporosis 
(1). From the age of 50, the residual lifetime risk of fracture is 47% for women and 22% for men 
(2). In women, the lifetime risk of hip fracture is equivalent to or higher than the risk of invasive 
breast cancer (3). More importantly, individuals with a hip fracture are at risk of further fracture and 
mortality (4). Bone mineral density (BMD) is the most important predictor of fracture risk and 
mortality following a fracture. Each standard deviation decrease in BMD is associated with an 
approximately 3-fold increase in fracture risk (5). Therefore, the diagnosis of osteoporosis is based 
on measurement of BMD.  
 
In recent years, evidence has emerged that osteoporosis and obesity are linked. Obesity is a major 
public health risk and is now a worldwide epidemic, with a recent global analysis highlighting a 
27% increase in overweight and obesity for adults between 1980 and 2013 (6). Despite its 
association with various metabolic dysfunctions, obesity has been thought to provide some 
protection against osteoporotic fractures, with high body mass indices (BMIs) said to be correlated 
with increased BMD (7). However, this view that obesity has bone-strengthening effects is now 
being questioned, with studies showing that the positive linear relationship between BMI and BMD 
is weaker at high BMIs (8), and other studies suggesting that severe obesity (BMI ≥ 35 kg/m2) may 
be a risk factor for certain types of fractures (9-11). For instance, a study involving over 60,000 
women from 10 countries revealed an association between BMI ≥ 30 kg/m2 and increased risk of 
ankle and upper leg fractures (with reduced risk of wrist fractures) (10), and a similar correlation 
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was also found in men, albeit only after correction for the increased BMD generally associated with 
obesity (11) and not without controversy (12). 
 
Whether or not obesity per se has an effect on fracture risk, emerging evidence suggests that obesity 
treatment, namely bariatric surgery – which induces weight losses of up to 75% of excess body 
weight which are maintained for up to 10-14 years post surgery (13) – results in bone loss (14, 15) 
However diet-induced weight loss, not bariatric surgery, with or without concomitant physical 
activity, is seen as the first treatment option for overweight and obesity (16). Given that weight loss 
via lifestyle modification is also known to induce hormonal changes which would be expected to 
reduce both lean body mass (17) and  bone mass (18, 19), an increasing number of studies have 
investigated changes in bone mass in response to diet-induced weight loss in overweight and obese 
individuals. 
 
Of the studies that have investigated changes in bone mass in response to diet-induced weight loss 
in overweight or obese adults, the results have been highly variable, with increases (20-24), 
decreases (25-40) and no change (22, 24, 26, 30, 33, 41-49) in bone mass being reported. Thus, 
attempting to draw sound conclusions from these mixed results is extremely difficult. However, 
definitive knowledge about any effects of diet-induced weight loss on bone is becoming 
increasingly important, given the large numbers of people in our increasingly overweight and obese 
world population who are dieting for weight reduction. For instance, in 2011-2012, 17% (or 1.6 
million) of the 9.2 million people in Australia who were overweight or obese reported being on a 
weight reducing diet (50). Although there have been a few previous reviews examining the effect of 
diet-induced weight loss on bone (51-53), a formal quantitative assessment of its effect on bone 
health has not been performed.  In the presence of conflicting findings from studies with limited 
sample sizes, a meta-analysis can be helpful in resolving the effect size. We thus conducted a 
systematic review and meta-analysis to quantitatively determine the effects of diet-induced weight 
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loss interventions of any duration on bone mass as well as on circulating or urinary concentrations 
of biomarkers (‘markers’) of bone formation or bone resorption (turnover) in overweight or obese 
men and women who were otherwise healthy. We included bone turnover markers in order to 
provide more sensitive assessment of the effects of diet-induced weight loss on bone in overweight 
and obesity, because measurement of bone turnover markers can reveal treatment effects after only 
2-3 months compared to a minimum of 6 months required before significant changes in BMD can 
be detected (54, 55). 
 
2.3 Materials and Methods 
2.3.1 Inclusion and exclusion criteria for selecting studies for this review  
Study designs included in this analysis were randomized controlled trials, pilot studies and cohort 
studies. Only original research studies were included; review articles, as well as abstracts and 
conference papers, were excluded. Included studies involved participants aged 18 years or above 
who were overweight or obese (BMI greater than or equal to 25 kg/m2) but otherwise healthy. 
Therefore, studies that specifically recruited participants with diseases such as type 2 diabetes, 
osteoporosis or cardiovascular disease were excluded. Included studies were required to implement 
a dietary weight loss intervention involving the restriction of energy intake relative to participants’ 
measured or estimated energy requirements and resulting in a reduction in average body mass of the 
group overall. No limit was placed on duration of the diet-induced weight loss period. Studies were 
excluded if participants had undergone bariatric surgery or were taking medications designed to 
induce weight loss. Studies were also excluded if the intervention involved calcium 
supplementation or supervised exercise, or if exercise was the primary means of eliciting weight 
loss, due to potential confounding effects of calcium supplementation (35, 56) or physical activity 
on bone mass (57). Because physical activity is frequently recommended for weight management, 
to reduce publication bias we included interventions in which exercise was recommended as part of 
a healthier lifestyle, provided that the exercise was not supervised or was not the primary focus of 
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the intervention. Any eligible non-surgical, non-medication, non-supplementation or non-exercise 
arms of any of the above such studies were included in this review. 
 
Studies were included where one or more of the following outcomes were assessed: BMD of the 
total hip, lumbar spine (L1-L4 or L2-L4) or total body, as determined by dual energy X-ray 
absorptiometry (DXA), or serum concentrations of N-terminal propeptide of type I procollagen 
(P1NP) or osteocalcin (both bone formation markers), serum concentrations of C-terminal 
telopeptide of type I collagen (CTX), or serum or urinary concentrations of N-terminal telopeptide 
of type I collagen (NTX) (bone resorption markers). We chose to investigate BMD of the hip and 
spine because these parameters are clinically relevant and are included in fracture risk algorithms, 
notably the World Health Organization’s Fracture Risk Assessment tool (FRAX®) and the Garvan 
Fracture Risk Calculator (58). Indeed, the hip is the gold standard site both for the diagnosis of 
osteoporosis and the assessment of fracture risk (59, 60). The spine, like the hip, is clinically 
significant due to its correlation with fracture risk (60-62). Both of these sites, due to their high 
trabecular bone content and thus high bone surface area, are highly susceptible to factors that 
influence bone metabolism (63). Although total body BMD is not used clinically for the diagnosis 
of osteoporosis or the estimation of fracture risk (63), many studies  have reported total body BMD, 
making it important to consider this parameter so as not to introduce bias in study selection. We 
chose to search for the above-mentioned bone turnover markers because while there is currently no 
standardised set of bone markers for use in clinical practice and research, there have been several 
recent international recommendations to measure serum P1NP and CTX as the standardised 
reference markers of bone formation and resorption, respectively (64-66). Although it has not been 
recommended to determine serum osteocalcin and serum or urinary NTX concentrations as markers 
of bone formation and resorption, respectively, they are also still commonly measured in 
conjunction with one or more of the recently recommended markers. Osteocalcin is of particular 
interest given a recent study demonstrating a significant association between serum osteocalcin – 
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but not P1NP or CTX – concentrations with incident fracture risk in older men, even after adjusting 
for other risk factors (67). To be included in this review, studies had to provide a within-subject 
comparison between baseline (i.e. before commencement of the dietary weight loss regime) and a 
time point immediately upon completion of the dietary regime.  
 
2.3.2 Search strategy 
MEDLINE, PreMEDLINE, Embase, Cinahl, and Sport Discuss were searched from the inception 
date of each database to March 2014. Both medical subject headings (MeSH) and free text search 
terms were employed.  Limitations were set so that only studies published in English and involving 
human participants were found. Reference lists of relevant articles as well as review articles were 
searched to help ensure that all relevant studies were found. The Supplementary Methods shows an 
example of the specific key words (or MeSH terms) that were used for the search of MEDLINE for 
population, intervention and outcomes.  
 
2.3.3 Data collection, extraction and analysis  
Two independent authors (JZ and MSHS) screened the titles and abstracts of studies identified in 
the above search strategy. The full texts of potentially relevant studies were retrieved, and the 
inclusion and exclusion criteria were applied. If discrepancies arose as to which studies to include, 
consensus was reached by consultation with a third author (RVS). The following data was extracted 
from each study, as summarized in Supplementary Table 1: the number of participants in the 
study (sample size), the sex, menopausal status, age and baseline BMI of participants (calculated 
from height and weight where BMI was not reported), duration and details of the dietary weight 
loss intervention, time points at which outcomes were collected and used in this review, baseline 
weight, weight change from baseline at the end of the intervention, and results from one or more of 
the following parameters: BMD of the total hip, lumbar spine (L1-L4 or L2-L4) or of the total body, 
or circulating or urinary P1NP, osteocalcin, CTX and NTX concentrations. 
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Some studies included more than one intervention that matched our inclusion criteria (20, 22, 26, 
28, 29, 32, 37, 42, 43, 68-70). In these instances, data from the different dietary weight loss 
interventions were not pooled but were instead treated as independent interventions. For studies that 
reported both sexes independently (20-22, 24, 29, 42, 44, 71-75), data from both sexes were pooled 
before inclusion in our analysis. This is because the majority of studies did not report males or 
females separately, or did not include both sexes within their population.  
 
Heights and weights were converted to m and kg, respectively, when data were not already reported 
or provided in these formats. The durations of dietary weight loss interventions were expressed in 
months, with 1 month corresponding to 4 weeks for intervention durations that were reported in 
weeks. Dietary interventions that were not 2, 3, 6, 12 or 24 months in duration were rounded to the 
nearest of these durations and included in that group for analysis, as shown in Supplementary 
Table 1. Some interventions measured additional time points between baseline and the end of the 
dietary intervention. These shorter time points were also included as separate interventions, because 
they reflect the effect of shorter dietary interventions. Energy prescriptions for dietary weight loss 
interventions were tabulated in kJ, with studies reporting energy prescriptions in calories being 
converted to kJ by multiplying by 4.18. A very low energy diet (VLED) was defined as a diet 
providing less than 3.4 MJ per day (76, 77), and a low energy diet (LED) was defined as a diet 
providing greater or equal to 3.4 but less than 5 MJ per day (76). A moderately energy restricted 
diet (MER) was defined as a diet providing greater or equal to 5 MJ per day (78). BMD in all 
studies was reported as g/cm2. Data for lumbar spine BMD measured between L1-L4 were pooled 
with data measured between L2-L4. In all studies, serum P1NP concentrations were reported in 
µg/L. Serum concentrations of osteocalcin were reported by studies in either nmol/L or µg/L. For 
this analysis we converted all data for osteocalcin to nmol/L using the molecular weight of 
osteocalcin as 5800 (79). The included studies reported serum concentrations of CTX in nmol/L or 
µg/L, depending on which manufacturer’s assay was used. As these methods are not comparable to 
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each other, no conversion equation is available. Thus, data for serum CTX concentrations were 
separated according to the units reported by the original studies (nmol/L or µg/L). NTX 
concentrations were also analysed in two distinct data sets due to measurements having been made 
either in serum or urine, both of which also have their own units of measurement and non-
comparable concentrations; nmol/L bone collagen equivalents (BCE) for serum, and nmol/L BCE / 
nmol/L creatine for urine. Corresponding authors were contacted if any required data was not 
available from the publication or was published in a format different from that required for this 
meta-analysis (20, 22-25, 28, 35-37, 39, 42-47, 69-71, 73, 74). For authors from whom we did not 
receive a response (24, 49, 75), data for their publications were analysed qualitatively rather than 
quantitatively.  
 
2.3.4 Data synthesis and analysis 
Our primary outcomes were the change in BMD at the total hip, lumbar spine and total body, and 
secondary outcomes were the change in serum P1NP, serum osteocalcin, serum CTX and serum or 
urinary NTX concentrations from baseline (i.e. before commencement of the dietary weight loss 
intervention) to a time point immediately after the dietary intervention. Weight loss between 
baseline and the end of the dietary intervention was also analysed.  
 
The synthesis of data was performed with a random-effects meta-analysis model. Briefly, we 
calculated effect size and its variance for each study. The effect size, di, was the weighted mean 
difference between measures taken before and after the dietary weight loss intervention, with the 
weight being inverse to the variance for each study. It is assumed that each di is normally 
distributed with a "true" but unknown mean of ti and a within-study variance of 2iσ .  The collection 
of i across studies is further assumed to follow a normal distribution with an unknown mean of δ0 
and a between-study variance of s2.  The random-effects model recognizes the possibility of 
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heterogeneity of between-study variation (i.e., that n2 could be different from 0) but with a fixed 
value.  
 
The heterogeneity of effects across studies was assessed by computing the coefficient of 
inconsistency (I2), which is the proportion of total variation among studies that is due to between-
study heterogeneity. An I2 exceeding 50% is regarded as evidence of substantial heterogeneity, 
indicating that secondary analyses are required to determine whether differences in primary 
outcomes may be due to differences in various parameters among participants. We decided a priory 
that if substantial heterogeneity was observed between studies, we would conduct sub-group 
analyses for the type of dietary weight loss intervention under study (VLED or LED versus MER) 
and menopausal status (pre- versus post-menopausal). In order to avoid duplication of data in these 
sub-group analyses, changes from baseline to the end of the dietary intervention were included in 
the analysis, but changes from baseline to any additional time points measured before the end of the 
intervention were not. Because of the limited number of studies available, duration of dietary 
intervention was not taken into account for such sub-group analyses, with all studies being pooled 
into their corresponding type of dietary intervention or menopausal status regardless of diet 
duration. To further explore any heterogeneity identified, we also conducted meta-regression 
analysis of change in the parameter of interest versus baseline body weight and baseline BMD. It 
was not possible to assess whether other differences amongst participants (i.e. sex and age) 
contributed to differences in primary outcomes, because separate data from men or women or from 
people of clearly defined age groups were not available for most studies. 
 
Publication bias was investigated visually with a funnel plot and confirmed with an Egger’s test. 
Due to the nature of this meta-analysis, where data were compared before and after an intervention, 
the usual quality filters that apply to randomized controlled trials or observational studies could not 
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be applied. All statistical analyses were conducted using STATA software version 13.0 (StataCorp, 
Texas, USA). 
 
2.4 Results 
2.4.1 Characteristics of clinical trials  
As seen in Supplementary Figure 1, 3145 publications were retrieved from the 5 databases 
searched, equating to 2765 unique publications. Following screening of titles and abstracts, the full 
texts of 71 publications were then retrieved and analysed against the inclusion and exclusion 
criteria, resulting in the exclusion of 30 publications for the reasons shown in Supplementary 
Figure 1. There were no further publications identified from screening references lists of these 71 
full-text publications. As a result, 41 publications were included in this report, with 38 of them 
being included in the meta-analysis and the other 3 (24, 49, 75) being analysed qualitatively; 31 
reporting on BMD outcomes (29 being included in the meta-analysis) and 23 reporting on bone 
turnover markers (21 of which were included in the meta-analysis) (Supplementary Figure 1).  
 
The publications included in this report are listed alphabetically in Supplementary Table 1. 
Sample sizes varied from n = 9 to 164, averaging at 46 participants per study. The studies included 
either males and females or females only, with females being divided in some cases into pre- and 
post-menopausal status (Supplementary Table 1). The lowest reported mean age of any study was 
33.7 years, and the greatest mean age was 70 years. BMI was of a minimum mean average of 25.6 
kg/m2 (overweight) and a maximum mean average of 39.3kg/m2 (obese). Mean body weight for 
participants in the included studies ranged from 67.2 to 111.6 kg.  
  
A number of publications reported on multiple dietary interventions, such as normal protein and 
high protein diets, so the total number of interventions for this meta-analysis reported in the 38 
publications was 53. Dietary weight loss interventions differed amongst studies with respect to both 
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the duration and details of intervention (Supplementary Table 1). A number of publications 
measured outcomes for each intervention at more than one time point (e.g. after 3 and 6 months on 
a 6-month intervention), and the total number of observations for these 38 publications and 53 
interventions was 64.   
 
2.4.2 Total hip BMD  
Summary. This meta-analysis shows significant reductions by 0.010-0.015 g/cm2 in total hip BMD 
after dietary weight loss interventions of 6-24 months in duration. There was significant 
heterogeneity of effects among interventions, partly due to differences in energy restriction (there 
was a significant reduction in total hip BMD with MER but not with severe energy restriction via 
VLED or LED). Heterogeneity could not be attributed to differences among participants in 
menopausal status or baseline body weight or baseline total hip BMD.  
 
Total hip BMD data were available from 13 interventions with 23 observations and 889 
participants. The average weight losses ranged from 7 to 11 kg (Figure 1A), depending on the 
duration. Mean ± SEM of total hip BMD at baseline were 1.01 ± 0.02 g/cm2. Total hip BMD 
decreased at all time points investigated (3, 6, 12 and 24 months), significantly so at 6 months (-
0.010 [-0.014, -0.005] g/cm2, P = 0.001), 12 months (-0.015 [-0.021, -0.008] g/cm2, P = 0.001), and 
24 months (-0.012 [-0.024, 0.000] g/cm2, P = 0.047), as shown in Figure 1A. Significant 
heterogeneity was found amongst interventions lasting 12 months and 24 months, but not amongst 
those of 3- or 6-month duration, as seen from the I2 statistics in Figure 1A.  
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Figure 1. Forest plot of change in (A) total hip BMD (bone mineral density) and (B) serum 
osteocalcin from baseline until the end of dietary weight loss interventions of varying 
durations. Mean weight changes (MWC) during the dietary interventions are recorded next to the 
corresponding duration, ± standard deviations. The letter in parentheses to the right of each study is 
used to distinguish different dietary interventions from the same publication, with details of all 
corresponding dietary interventions listed in Supplementary Table 1. Plotted values (and the 
numbers at right) represent the absolute changes in (A) total hip BMD (in g/cm2) and (B) serum 
osteocalcin concentrations (in nmol/L), with 95% confidence intervals (CI) illustrated by the error 
bars (or the numbers in parentheses at right). Mean ± SEM of total hip BMD and serum osteocalcin 
concentrations at baseline were 1.01 ± 0.02 g/cm2 and 1.6 ± 0.5 nmol/L, respectively. I2 indicates 
the percentage of heterogeneity for the dietary interventions of each duration. 
 
Due to this significant heterogeneity in the data at 12 and 24 months, sub-group analyses were 
conducted to explore for potential contributing factors. All interventions were divided according to 
A" B"
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the degree of energy restriction (VLED or LED versus MER as outlined in the Methods section), 
regardless of the duration of the dietary intervention. Weight loss was greater with VLED or LED (-
11.1 [-14.4, -7.8] kg, P = 0.001 versus baseline), than with MER (-9.6 [-10.8, -8.6] kg, P = 0.001 
versus baseline). Although total hip BMD decreased with both types of dietary intervention, the 
decrease was significant only with MER (-0.013 [-0.018, -0.008] g/cm2, P = 0.001). Menopausal 
status had no significant effect on the effect of weight loss on total hip BMD (data not shown). To 
further explore possible reasons for the heterogeneity in outcomes, we conducted a meta-regression 
analysis of change in total hip BMD versus baseline body weight and baseline BMD using the 13 
studies that investigated total hip BMD after 6 or 12 months. However, this analysis did not show 
any linear relationship between change in total hip BMD and baseline body weight (P = 0.757) or 
baseline BMD (P = 0.467), suggesting that differences in these baseline parameters could not 
account for variability in the results. This finding also suggests that the reduction in total hip BMD 
was unlikely due to the statistical phenomenon of regression toward the mean, whereby variables 
that are higher or lower than the mean upon first measurement will tend to be closer to the mean the 
next time they are measured, even without intervention. The Egger’s test and funnel plot revealed 
no significant publication bias for the change in weight (P = 0.967) or total hip BMD (P = 0.492).  
 
2.4.3 Lumbar spine BMD 
Summary. This meta-analysis shows no significant overall effect of diet-induced weight loss on 
lumbar spine BMD. However, there was significant heterogeneity of effects among interventions. 
This heterogeneity was related to differences in energy restriction and menopausal status, with a 
significant decrease in lumbar spine BMD in interventions involving VLED or LED but not MER, 
and in interventions involving pre- but not post-menopausal women.  
 
BMD at the lumbar spine showed variable responses to diet-induced weight loss, with increases, 
decreases and no change in this parameter being found from the baseline mean ± SEM values of 
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1.16 ± 0.03 g/cm2 in a total of 20 interventions and 29 observations in 1,097 participants, with no 
overall significant differences being identified by this meta-analysis at any time point 
(Supplementary Figure 2). Significant heterogeneity between studies was present at 3 and 12 but 
not at 6 or 24 months. VLED or LED caused a significant decrease in BMD of the lumbar spine 
across all time points (-0.031 [-0.062, 0.000] g/cm2, P = 0.05), with no significant change in this 
parameter in response to MER (0.002 [-0.003, 0.007] g/cm2, P = 0.497). This result was opposite to 
that found for the total hip as described above, where BMD was significantly decreased only in 
response to MER and not in response to VLED or LED. When menopausal status was investigated, 
BMD of the lumbar spine decreased significantly only in pre-menopausal women (-0.023 [-0.005, 
0.000] g/cm2, P = 0.05) and not in post-menopausal women (0.002 [-0.011, 0.016] g/cm2, P = 
0.726). Therefore, although no significant effect of diet-induced weight loss on lumbar spine BMD 
was found when the data were pooled according to the duration of dietary interventions, significant 
effects were found when the studies were analysed according to the diet type and menopausal status 
of the participants. No evidence of publication bias was found.  
 
2.4.4 Total body BMD 
Summary. Apart from a significant decrease of 0.011 g/cm2 in total body BMD after dietary weight 
loss interventions of 6 months in duration, this meta-analysis showed no overall effect of diet-
induced weight loss on total body BMD. There was significant heterogeneity of effects among 
interventions, related to differences in energy restriction (there was a significant increase in total 
body BMD with VLED or LED but not MER), and differences in menopausal status (there was a 
significant decrease in total body BMD in post- but not pre-menopausal women).  
 
Supplementary Figure 3 depicts the forest plot for the change in BMD of the total body in 
response to diet-induced weight loss in 32 interventions and 37 observations including a total of 883 
participants (mean ± SEM at baseline of 1.17 ± 0.02 g/cm2). For dietary interventions of durations 
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of 3 and 12 months, no significant changes from baseline in total body BMD were found (P = 
0.119, and P = 0.619, respectively). For dietary interventions that had a duration of 6 months, 
however, a significant decrease from baseline in total body BMD was observed (-0.011 [-0.018, -
0.003] g/cm2, P = 0.004). Significant heterogeneity was observed for interventions of 3 and 12 
months’ duration. VLED or LED resulted in a significant overall increase in total body BMD (P = 
0.001) compared to a non-significant increase in this parameter in response to MER (P = 0.59). 
While both pre- and post-menopausal women lost a similar amount of body weight, and while 
BMD of the total body decreased in both pre- and post-menopausal women, the effect of diet on 
total body BMD was significant only in the post-menopausal women (P = 0.006). This finding is 
different to that identified above, where no change in total hip BMD was found in either pre- or 
post-menopausal women, and a significant decrease in lumbar spine BMD was only detected in the 
pre-menopausal cohort. No publication bias was detected. 
 
2.4.5 N-terminal propeptide of type I procollagen (P1NP) 
There were 8 interventions and 10 observations that investigated the effect of diet-induced weight 
loss on serum concentrations of the bone formation marker, P1NP, in a total of 176 participants 
with a mean ± SEM at baseline of 40.8 ± 3.3 µg/L. Serum P1NP concentrations showed no 
significant change in response to diet at any time point (Supplementary Figure 4). No 
heterogeneity was observed for serum P1NP.  
 
2.4.6 Serum osteocalcin 
Summary. This meta-analysis showed that 3-month diet-induced weight loss interventions were 
associated with a significant increase in serum osteocalcin concentrations. However, the effect was 
not observed when measured after interventions of 6, 12 or 24 months in duration. There was 
significant heterogeneity among studies, due at least in part to differences in energy restriction but 
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not menopausal status, with a significant increase in osteocalcin being observed after MER but not 
after VLED or LED.  
 
There were 25 interventions and 32 observations that investigated the effect of diet-induced weight 
loss on serum concentrations of the bone formation marker, osteocalcin, in a total of 827 
participants with a mean ± SEM at baseline 1.6 ± 0.5 nmol/L. Overall, serum osteocalcin 
concentrations tended to increase with diet-induced weight loss (Figure 1B), with a significant 
increase occurring in response to dietary interventions of 3 months’ duration (0.26 [0.13, 0.39] 
nmol/L, P = 0.001). Heterogeneity was present only at 12 months. Weight reduction was greater 
with VLED or LED (-13.7 [-23.3, -4.2] kg, P = 0.005 versus baseline) than with MER (-6.8 [-23.3, -
6.1] kg, P = 0.001 versus baseline). However, a significant increase in osteocalcin was only found 
in response to the MER (0.10 [0.01, 0.19] nmol/L, P = 0.025 versus baseline) and not in response to 
the VLED or LED (0.23 [-0.68, 1.13] nmol/L, P = 0.624 versus baseline). This finding is consistent 
with that for BMD of the total hip, where a significant decrease occurred in response to MER but 
not VLED or LED, yet opposite to that for the lumbar spine, which favored MER over VLED for 
effects on BMD. No significant changes from baseline to the end of the dietary intervention were 
present with the limited number of interventions having a specifically pre- or post- menopausal 
status (pre-menopausal, 0.17 [-0.14, 0.48] nmol/L, P = 0.290; post-menopausal, 0.06 [-0.06, -0.18] 
nmol/L, P = 0.320). There was no publication bias. 
 
2.4.7 Serum C-terminal telopeptide of type I collagen (CTX)  
Serum CTX was investigated and reported in nmol/L units in 5 interventions and 5 observations 
with a total of 103 participants, all with a 3-month duration and a mean ± SEM at baseline of 12.5 ± 
1.5 nmol/L (Supplementary Figure 5). A significant increase in this parameter was observed (4.72 
[2.12, 7.31] nmol/L, P = 0.001 versus baseline). There was no significant heterogeneity detected, so 
no secondary analyses were performed for this parameter. Serum CTX was investigated and 
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reported in µg/L units in 8 interventions and 10 observations involving 486 participants overall and 
a mean ± SEM at baseline of 0.51 ± 0.09 µg/L (Supplementary Figure 6). There was a non-
significant trend for an increase in this parameter for interventions of 2 months’ duration, and a 
significant increase for interventions of 3 months’ duration (0.21 [0.13, 0.29] µg/L, P = 0.001 
versus baseline), albeit that finding stems from the results of a single intervention (71). However, 
dietary interventions that were 6, 12 or 24 months in duration produced no overall significant 
change in serum CTX concentrations compared to baseline and reported in µg/L (Supplementary 
Figure 6). Significant heterogeneity for serum CTX in µg/L occurred at 6 and 12 months, but sub-
group analysis was not performed for this parameter due to the limited number of studies available. 
Indeed, only 1 study that investigated serum CTX in µg/L used an LED, and only 1 study 
investigated a distinctly pre-menopausal population.  
 
2.4.8 Serum and urinary N- terminal telopeptide of type I collagen (NTX) 
There were 14 interventions and 17 observations that investigated serum or urinary NTX 
concentrations in a total of 306 participants. For both serum (Supplementary Figure 7) and urinary 
(Supplementary Figure 8) concentrations of the bone resorption marker NTX, there was an overall 
trend for an increase from baseline mean ± SEM values of 15.5 ± 1.2 nmol/L BCE and 37.4 ± 4.1 
nmol/L BCE / nmol/L creatine, respectively, in response to diet-induced weight loss. A significant 
increase only occurred for serum NTX in response to a 2-month diet-induced weight loss 
intervention, albeit this time point only included one study (80) (3.70 [0.90, 6.50] nmol/L BCE, P = 
0.010 versus baseline). No heterogeneity was observed for serum or urinary NTX. 
 
2.4.9 Qualitative analysis of studies that could not be included in the meta-analysis 
For the 3 publications (49, 75, 81) that were not able to be included quantitatively in this meta-
analysis, the findings are broadly consistent with results from the meta-analysis. Svendsen (1993) 
(49) placed 50 overweight post-menopausal women on a diet involving MER for 3 months, thereby 
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inducing significant weight loss (-9.5 ± 0.4 kg, P = 0001 versus baseline). Lumbar spine and total 
body BMD were investigated, with non-significant decreases being observed in both parameters 
when measured at 3 months. The second study, by Thorpe (2008) (24), investigated the effect of a 
12-month high protein or high carbohydrate weight-reducing diet on total hip, lumbar spine and 
total body BMD in 130 male and female participants. In the cohort on the high protein weight-
reducing diet, BMD was significantly increased at all sites investigated, whereas the cohort on the 
high carbohydrate weight-reducing diet showed a non-significant trend towards decreased BMD at 
all three sites (total hip, lumbar spine and total body). Hyldstrup (1993) (75) investigated serum 
osteocalcin concentrations in 44 obese men and women undergoing a VLED for 2 months, with 24 
participants continuing to 8 months on the diet. A significant increase in serum osteocalcin 
concentrations occurred at 2 months, and this increase over baseline values was still present when 
measured at 8 months, with no significant difference between values recorded at 2 and 8 months. 
 
2.5 Discussion  
Whether or not diet-induced weight loss exerts an adverse effect on bone health has been a 
controversial issue. In this study, by using a meta-analysis approach, we have demonstrated that 
dietary weight loss interventions were associated with a small but statistically significant reduction 
in total hip BMD, and the effect could be seen from the sixth month of intervention onwards. We 
did not, however, find any significant effect of diet-induced weight loss on BMD of the clinically 
relevant site of lumbar spine. Importantly, we found that the decrease in total hip BMD occurred 
subsequent to statistically significant increases in serum concentrations of osteocalcin, CTX and 
NTX, suggesting that weight loss diets increase bone turnover, albeit perhaps only transiently, with 
consequences for total hip but not spine BMD.  
 
While the effect was small, several lines of evidence support a real effect of diet-induced weight 
loss to reduce total hip BMD. First, of the less than 25% of studies in this review that included a 
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control group (22, 25, 36, 40, 45-47, 73, 74, 80, 82), there were no significant changes in BMD (22, 
25, 46, 47) or bone turnover markers (22, 36, 45-47, 73, 80) in the control group over the time 
frames investigated in this review, with the exception of 4 studies (36, 40, 45, 74) investigating 
post-menopausal women or people older than 65 years of age. Secondly, the Dubbo Osteoporosis 
Epidemiology Study showed that women with a baseline body weight over 70 kg did not show any 
reduction in BMD over an average interval of 2.7 years, in contrast to the significant bone losses 
seen in women weighing up to 70 kg (83). Therefore, as the mean baseline body weight of 
participants in all but one (34) of the studies included in our meta-analysis was over 70 kg, it is 
likely that loss of total hip BMD in this population was a real effect of diet-induced weight loss. 
Thirdly, the significant increases in circulating concentrations of bone turnover markers suggest a 
bone catabolic state. It is important to consider bone turnover markers in this field of research, 
because the accuracy and precision of DXA is known to decrease with increasing BMI (84) and 
when participants undergo changes in body weight (85-88), and because BMD measured at time 
points earlier than 6 months are not considered to be clinically significant, since a complete cycle of 
bone remodeling takes 4 to 6 months (53). Thus, diet-induced weight loss induces small but 
statistically significant losses in total hip BMD that would likely not otherwise be seen in 
overweight or obese individuals.  
 
It is not clear whether the significant reduction in total hip BMD represents a maladaptive change, 
or whether it simply represents normalization of BMD relative to reduced body mass after diet-
induced weight loss, akin to the finding that a certain loss of percent fat free mass is to be expected 
in response to reduced BMI (89). The statistically significant decreases in BMD observed in this 
meta-analysis (-0.010 to -0.015 g/cm2) represent an approximately 1 to 1.5% change from baseline 
values, which is similar to the average yearly BMD loss for elderly women (83, 90). In an untreated 
population, each standard deviation decrease in femoral neck BMD (which is 0.12 g/cm2) was 
associated with an approximately 3.5-fold increase in the risk of hip fracture (91). Thus, it can be 
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estimated that a 0.010 to 0.015 g/cm2 decrease in BMD is equivalent to an approximately 10 to 15% 
increase in fracture risk. Thus, it would appear unlikely that a single dietary weight loss intervention 
of 6-24 months’ duration would have any prevailing negative impact on bone, and should be safe 
for most overweight or obese people. However, given that long-term obesity management typically 
involves multiple periods of diet-induced weight loss, repeated at intervals over many years, 
potential cumulative adverse effects on bone should be considered, especially in those at risk of 
accelerated bone loss such as older or inactive women (83). In keeping with this possibility, a 
prospective cohort study in 6,785 lean and overweight or obese women aged 65 years and over 
found that losing 5% or more of initial body weight over an average 5.7-year period, whether 
intentionally or unintentionally and irrespective of current weight, significantly increased the rate of 
hip BMD loss and doubled the risk of hip fracture (90). Moreover, a population-based study of 
20,745 men and women in Tromsø, Norway, showed that women who recalled dieting and losing 
11 kg or more, or who recalled 11 or more dieting episodes, had an adjusted hazard ratio for non-
vertebral osteoporotic fractures of 1.48 or 1.73 in a mean follow-up period of approximately 12 
years, compared to women with no recollection of dieting (92). Thus, while a single diet-induced 
weight loss intervention may not increase fracture risk by a clinically relevant degree, caution may 
be warranted for repeated episodes of diet-induced weight loss.  
 
Unlike the total hip, no significant effect of diet-induced weight loss was observed in the lumbar 
spine. This may be due in part to the greater measurement error that occurs in the lumbar spine in 
comparison to the hip (53). DXA scans of the spine, in particular the lumbar region (L1- L5), often 
pick up calcification from other sources besides healthy vertebrae, and this increases apparent BMD 
readings (93, 94). Such calcification can originate from atherosclerotic lesions within the aorta, or 
from osteophytes (protrusions of bone tissue that form in response to joint damage from conditions 
such as in arthritis), masking underlying changes in bone mass due to age or disease or other factors 
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(93, 95). Therefore the validity of lumbar spine BMD results can be questionable, highlighting the 
greater reliance on total hip BMD measures for the estimation of fracture risk (58, 60, 64, 82, 96). 
 
The majority of studies identified in this systematic review and meta-analysis investigated total 
body BMD, which was significantly reduced by 6-month (but not by 3- or 12-month) weight loss 
interventions.  However, measures of total body BMD are not clinically relevant because they do 
not identify specific areas that are affected by loss of bone mass. In osteoporosis, bones with a high 
proportion of trabecular as opposed to cortical bone tissue, such as the hip and spine, have an 
increased likelihood of degradation (63). When sub-regions of whole body DXA scans, such as the 
pelvis, are used to measure BMD rather than the total hip or proximal femur, under diagnosis of 
osteoporosis occurs (97, 98). Therefore, local DXA scans of specific bone regions should be 
performed rather than, or in conjunction with, total body scans when investigating BMD.  
 
We initially hypothesized that any diet-induced reductions in BMD and increases in bone turnover 
would be more clearly apparent after interventions involving VLED or LED than those involving 
MER, due to the greater severity of energy restriction used. This is because energy restriction 
induces hormonal changes that might be expected to decrease bone mass (18, 53), and the effects 
may be more pronounced with severe than with moderate energy restriction (99). An additional 
rationale for this hypothesis is that severe energy restriction induces greater weight loss than MER 
(100), which would lead to greater mechanical unloading of bone, with subsequently greater bone 
loss. Mechanistic support for this comes from the finding that weight loss-induced reductions in 
BMD and bone quality in older adults are correlated with increases in circulating concentrations of 
sclerostin, an osteoblastic inhibitor released from osteocytes in response to mechanical unloading 
(101). Furthermore, we hypothesized that post-menopausal women would exhibit more detrimental 
changes in bone mass and turnover in response to diet-induced weight loss than pre-menopausal 
women, because they are already pre-disposed to detrimental changes in bone. However, our sub-
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group analyses did not provide any clear evidence to support or refute these hypotheses. The 
conflicting results identified emphasize the need for further investigation into the effects of diet 
types on bone, as well as interaction of the effect with menopausal status.  
 
The present findings should be considered within context of strengths and weaknesses. To the best 
of our knowledge, this is the first and the most comprehensive review of the effect of diet-induced 
weight loss on bone loss, as assessed in clinical trials. The measurement of BMD in individual 
studies was done with DXA technology, which is considered gold standard for the assessment of 
bone mass. However, it was not possible to determine the effects of sex or age on the changes in 
bone mass or turnover with weight loss. This is because the majority of studies investigated female 
populations only. In studies where both males and females were included (20-22, 24, 29, 42, 44, 71-
75), the two sexes were not always reported independently (22, 29, 42, 44, 74). Additionally, 
although age was reported in all studies, large age ranges prevented us from being able to assign the 
outcomes to a younger or older population for comparison. Another limitation of this meta-analysis 
was the widely varying types of dietary interventions. While we were able to categorize 
interventions according to the levels of prescribed energy intake, this did not take into account 
differences in macronutrient composition of the diets. A further limitation of this meta-analysis was 
that only 25% of the included studies involved comparison with a control group (22, 25, 36, 40, 45-
47, 73, 74, 80, 82), as discussed above.  
 
This meta-analysis has not only highlighted significant changes that occur in bone physiology in 
response to diet-induced weight loss, it has also crystallized gaps in the literature where further 
research is required. First, mathematical modeling and bone structural analyses would be required 
to determine whether the presently-observed changes in bone in response to diet-induced weight 
loss represent benign normalization of bone mass to the reduced body weight, or the onset of 
potentially pathological processes. Secondly, only a minority of studies hereby reviewed 
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investigated BMD at time points after the end of the dietary intervention (20, 21, 23, 25, 27, 28, 30, 
39, 74). This prevented us from being able to assess whether the changes that were observed 
immediately after finishing the weight loss diet persisted or resolved once the dietary intervention 
has ceased. Of the studies that did include a follow up time point (21, 23, 25, 27, 28, 30, 39, 74), 
decreases in BMD of the total hip (23, 30, 74), lumbar spine (25, 28, 30) and total body (21, 27, 28, 
30, 39) were still present when measured at 3 to 21 months after completion of the dietary weight 
loss intervention, raising potential concerns about the long-term impact of repeated weight loss diets 
on bone. Hence it would be important that future studies investigate the longitudinal effects of 
dietary weight loss interventions on bone, as in two current trials in our research team (102, 103). 
An additional outstanding question is the change in fracture risk that may occur as a result of BMD 
loss subsequent to diet-induced weight loss in overweight or obese people. None of the studies 
included in this analysis estimated change in fracture risk as a result of the diet, with only one study 
(23) reporting Z and T scores (which are needed to calculate fracture risk in some algorithms) in 
conjunction with BMD in g/cm2. Therefore, future research should aim to incorporate BMD values 
of the lumbar spine and / or hip, Z and T scores, as well as an assessment of fracture risk when 
investigating the influence of diet-induced weight loss on bone. Further research may also be 
needed to address the kinds of interventions that could aid in preventing bone loss in response to 
diet-induced weight loss. Currently there is some, but little evidence from randomized controlled 
trials indicating that calcium supplementation attenuates the bone loss that occurs with weight loss, 
and that a higher dietary protein intake and exercise (101) also have similar effects, as highlighted 
in two reviews (53, 104). Since this meta-analysis included diet-induced weight loss interventions 
with higher dietary protein intakes (but not those involving calcium supplementation), as well as 
those that recommended but did not supervise physical activity, the effect of diet-induced weight 
loss on bone may be even more pronounced than that suggested in the current analysis for 
individuals on lower protein weight loss diets and / or not engaging in regular physical activity. 
Additionally, while our sub-group analyses suggested that VLED or LEDs do not seem to have any 
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worse effect on bone than does MER, there were limited studies available testing VLEDs or LEDs, 
and only three (22, 28, 70) in direct comparison to less severe energy restriction (i.e. MER). Thus 
more work is needed in this domain, given the increasing use of severe energy restriction for the 
management of overweight and obesity.  
 
Obesity is a major health concern that requires treatment to prevent or attenuate associated health 
issues and diseases. This meta-analysis shows that BMD of the total hip decreases with diet-induced 
weight loss in overweight or obese people, in conjunction with an early rise in bone turnover, but 
the change induced by a single intervention is small in comparison to the benefits for metabolic 
health. Thus, clinicians should continue to recommend weight loss for the treatment of overweight 
and obesity, with support for weight maintenance after weight loss. 
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Chapter 3: Effect of diet-induced weight loss on muscle 
strength in overweight or obese adults – a systematic review 
and meta-analysis of clinical trials 
 
Revised manuscript re-submitted to Obesity Reviews on 26th February 2016 
 
3.1 Abstract  
We conducted a systematic review and meta-analysis to identify how diet-induced 
weight loss in adults with overweight or obesity impacts on muscle strength. 27 
publications, including 33 interventions, most of which were 8-24 weeks in duration, 
were included. Meta-analysis of 7 interventions measuring knee extensor strength by 
isokinetic dynamometry in 108 participants found a significant decrease following 
diet-induced weight loss (-9.0 [95% confidence interval: -13.8, - 4.1] N/m, P<0.001), 
representing a 7.5% decrease from baseline values. Meta-analysis of handgrip 
strength from 10 interventions in 231 participants showed a non-significant decrease 
(-1.7 [-3.6, 0.1] kg, P=0.070), with significant heterogeneity (I2=83.9%, P<0.001). 
This heterogeneity may have been due to diet type, because there was a significant 
decrease in handgrip strength in 7 interventions in 169 participants involving 
moderate energy restriction (-2.4 [-4.8, -0.0] kg, P=0.046), representing a 4.6% 
decrease from baseline values, but not in 3 interventions in 62 participants involving 
very low energy diet (-0.4 [-2.0, 1.2] kg, P=0.610). Due to variability in methodology 
and muscles tested, no other data could be meta-analyzed, and qualitative assessment 
of the remaining interventions revealed mixed results. Despite varying methodologies, 
diets and small sample sizes, these findings suggest a potential adverse effect of diet-
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induced weight loss on muscle strength. While these findings should not act as a 
deterrent against weight loss, due to the known health benefits of losing excess 
weight, they call for strategies to combat strength loss – such as weight training and 
other exercises – during diet-induced weight loss.  
 
3.2 Introduction 
Overweight and obesity are no longer issues affecting the minority. From 1980 to 
2013, the worldwide prevalence of people with a body mass index (BMI) greater than 
or equal to 25 kg/m2 rose by 27.5% (1). Excess body weight leads to a number of 
metabolic health problems (2-4), alongside poor physical performance and 
musculoskeletal disorders (5). 
 
To help combat the obesity crisis, a plethora of dietary weight loss programs have 
been devised, varying in macronutrient composition and level of energy restriction. 
While the aim of weight loss programs is to reduce excess fat, they also result in loss 
of fat free mass (6), possibly due to changes such as reduced circulating 
concentrations of insulin like growth factor-1 (IGF-1) or sex steroids (7-10), unless 
combined with a strength training program (11). Loss of fat free mass is associated 
with a reduction in muscle mass (12). Moreover, fat free mass is a known predictor of 
muscle strength (13, 14). Although loss of fat free (and muscle) mass is to be 
expected when a person is no longer carrying such a high body mass (15), there is no 
clear consensus about the effect that reductions in muscle mass may have on muscle 
functions, notably strength.  
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Muscle strength can be defined as the ability of a muscle to generate maximal force 
(16, 17). It is a function of both muscle mass and muscle quality, and is an indicator 
of one’s functional capacity (18). Muscle strength declines by 8-10% every decade 
from the age of 40 onwards (16), in a process known as dynapenia (19) – as opposed 
to sarcopenia, which is the age-related decline in muscle mass (19, 20). Not only does 
ageing reduce muscle strength; intentional weight loss may also have adverse effects. 
Indeed, diet- or diet and exercise-induced weight loss induces hormonal changes that 
would be expected to have negative effects on muscle strength (9, 10), possibly more 
so with severe than with moderate energy restriction (9, 21). Such an outcome would 
be detrimental, as lower muscle strength is associated with reduced mobility and a 
higher risk of falls and fractures, thereby negatively influencing ones functional 
ability to contribute to society (14, 22), as well as a higher risk of mortality (22, 23). 
Therefore, as our population is becoming increasingly aged and obese, and with 
greater numbers of people of all ages using dietary interventions to lose excess weight 
(24), it is crucial to identify whether diet-induced weight loss worsens muscle 
strength.  
 
The purpose of this systematic review and meta-analysis is thus to examine whether 
diet-induced weight loss in adults that are overweight or obese has an impact on 
muscle strength. This will help to clarify the need for, or direction of, future research 
in this area, and identify suitable methodologies for muscle strength assessment in the 
context of weight reduction programs in overweight or obese populations.  
 
3.3 Methods 
3.3.1 Inclusion criteria 
Muscle strength change with dietary weight loss  Chapter 3 
 
 65 
To be included in this systematic review, studies had to involve participants aged 18 
years or above who were overweight or obese (BMI ≥ 25 kg/m2), but were otherwise 
healthy. Included studies implemented an energy-restricted diet with the aim of 
achieving weight loss, with no limits placed on the duration of the dietary intervention 
period. Included studies were required to have measured muscle strength before and 
after the energy-restricted diet by one or more of one repetition maximum (1RM) 
strength testing, isokinetic dynamometry, isometric dynamometry, or handgrip 
strength testing (a form of isometric dynamometry), as these are the four most 
commonly applied methods of muscle strength testing. The first 3 methods can be 
applied to a range of muscle groups, as indicated in Table 1, in the column listing 
muscles examined and exercises used. 1RM strength testing measures the maximum 
weight that a person can lift or move in a single maneuver, such as a chest press (25). 
It uses isoinertial muscle contractions, meaning that the same maximum weight is 
being lifted (25). Isokinetic (dynamic) dynamometry measures the maximum force 
generated against a weighted load that is lifted or moved at a constant speed (16). On 
the other hand, isometric (static) dynamometry measures the maximum force 
generated in a sustained muscle contraction against an immovable load for a set time, 
typically 5 seconds (26). Articles were included if they were original research, with 
any study design accepted.  
 
3.3.2 Exclusion criteria 
Studies specifically involving participants with type 2 diabetes mellitus, osteoporosis 
or arthritis were excluded. Studies were excluded if participants had undergone 
bariatric surgery, were taking medications designed to induce weight loss, if the 
intervention involved supervised exercise, or if exercise was the primary means of 
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eliciting weight loss. Our rationale for excluding interventions involving supervised 
exercise or exercise as the primary weight loss mediator was that these are not usual 
in clinical practice, and dietary restriction is the most common means of eliciting 
weight loss. However, in order to reduce bias, those interventions that recommended 
exercise as part of a healthier lifestyle regime were included, provided that the 
exercise was not supervised or was not the primary focus of the intervention. Non-
surgical, non-medication or non-exercise arms of any of the above such studies were 
included in this review if eligible. Reviews, conference papers and abstracts were 
excluded.  
 
3.3.3 Data sources and search strategy 
An electronic search of the following databases was conducted from inception of each 
database to January 2015: Cinahl, Embase, Medline, Pre-Medline and Sportdiscus. 
Both medical subject heading (MeSH) terms and free text search strategies were 
employed, with limitations set for articles published in English and only involving 
human participants. The following example shows the specific key words (or MeSH 
terms) that were used for the search of MEDLINE for population, intervention and 
outcomes. 
 
 
Population  
exp overweight/ OR obesity/ OR obesity, abdominal/ OR obesity, morbid/ OR 
overweight.tw OR over weight.tw OR obes*.tw OR ((abdominal or 
subcutaneous or intra-abdominal or visceral or retriperitoneal or retro 
peritoneal) adj3 fat*).tw 
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Intervention 
diet/ OR diet*.tw OR diet, carbohydrate-restricted/ OR diet, fat-restricted/ OR 
diet, reducing/ OR diet, protein-restricted/ OR caloric restriction/ OR calor* 
restrict*.tw OR diet therapy/ OR weight loss/ OR weight los*.tw OR (weight 
adj5 (los* or reduc* or control* or decreas*)).tw OR ((low* or reduc* or 
restric*) adj3 (calori* or energy or protein or carb* or fat*)).tw 
Outcomes 
musc* function*.tw. OR muscle strength/ or hand strength/ or pinch strength/ 
OR musc* strength.tw. OR musc* performance.tw. OR Isometric Contraction/ 
OR (isometric adj2 force).tw. OR (isometric adj2 contraction).tw. OR 
(isometric adj2 strength).tw. OR (isokinetic adj2 strength).tw. OR strength 
assess*.tw. OR 1RM.tw. OR 1 RM.tw. OR rep* max*.tw. OR 
dynamomet*.tw. OR Muscle Strength Dynamometer/ OR max* 
contraction*.tw. OR (peak adj2 strength).tw. OR (peak adj2 torque).tw. OR 
(knee adj2 strength).tw. OR handgrip strength.tw. OR hand grip strength.tw. 
OR grip strength.tw. OR pinch strength.tw. OR (lower adj3 strength).tw. OR 
(upper adj3 strength).tw. OR extens* strength.tw. OR flex* strength.tw. 
 
Our final input command was population AND intervention AND outcomes. The 
example search strategy for MEDLINE (above) was adapted to suit each database. 
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3.3.4 Data extraction and analysis 
Two independent authors (JZ and MSHH) screened the titles and abstracts of studies 
identified in the above search strategy. The full text versions of articles that were 
potentially relevant were retrieved and the inclusion and exclusion criteria were 
applied. If discrepancies arose, a consensus was reached by discussion with a third 
author (RVS).  
 
The following data were extracted by JZ (and reviewed by MSHH) from each of the 
included publications, as summarized in Table 1; study details and design (first 
author, year published, sample size, sex, menopausal status, age and baseline BMI of 
the participants, duration of the intervention (in weeks), details of the dietary weight 
loss intervention; whether it was a very low energy diet (VLED, less than 3.4 MJ per 
day) (27, 28), low energy diet (LED, greater than or equal to 3.4 MJ but less than 5 
MJ per day) (27), or a diet involving moderate energy restriction (MER, greater than 
or equal to 5 MJ per day) (29), as well as the change in weight from baseline until the 
end of the diet, baseline fat free mass, how it was measured, the direction of any 
statistically significant change in fat free mass, if any, the method(s) of muscle 
strength assessment and muscles being examined, baseline muscle strength, the 
change in muscle strength from baseline until the end of the dietary intervention (both 
in absolute terms and as a percent of baseline), and the primary outcome of each 
publication.  
 
Our primary outcome was the change in muscle strength (assessed by 1RM testing, 
isokinetic dynamometry, isometric dynamometry or handgrip strength testing) in a 
pre-intervention versus post-intervention manner, rather than comparison to a control 
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group. This is due to the limited number of publications including a control or weight 
maintenance group in their protocol (30-36), with many publications comparing 
different energy restricted interventions or a dietary protocol with and without 
exercise. Some publications (37-42) had more than one dietary intervention that met 
the selection criteria, thus in these cases interventions were included in the analysis 
independently.  
 
Weights were converted to kg, and durations of dietary weight loss interventions were 
converted to weeks, when data were not already reported or provided in these formats. 
Conversion to weeks was made assuming 4 weeks in a month. Energy prescriptions 
for dietary weight loss interventions were tabulated in categories (VLED, LED or 
MER as described above), with studies reporting energy prescriptions in calories 
being converted to MJ by multiplying by 0.00418. Two publications using isokinetic 
dynamometry reported strength in foot/lb (34, 38): these data were converted to N/m 
by multiplying by 1.35581795.  
 
Separate meta-analyses were performed on data from studies that assessed muscle 
strength via isokinetic dynamometry (knee extension) and handgrip strength. There 
was no requirement to contact any authors for additional data. Data from all 
interventions examining muscle strength using the same assessment technique were 
pooled and expressed either in actual units, as they were all reported using (or 
converted to) the same units (N/m for isokinetic dynamometry of knee extension and 
kg for hand grip strength), or as a percent of baseline values. We used random effects 
meta-analysis to obtain pooled changes in muscle strength (both in absolute values 
and as a percent of baseline) for these parameters. We used this same technique to 
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obtain pooled changes in body weight and fat free mass (both in kg). Heterogeneity 
between studies was assessed using the I2 statistics. We decided a priori that if 
significant heterogeneity was detected amongst studies (as indicated by I2 being 
greater than 50%), we would undertake sub-group analyses to determine whether 
variability in muscle strength responses to dietary interventions could be due to 
differences in the degree of energy restriction. We hypothesized that severe energy 
restriction via VLED or LED would incur greater negative repercussions on muscle 
strength than MER. It was not possible to determine the effects of sex or age on the 
changes in muscle strength with weight loss. This is because in studies where both 
males and females were included, the two sexes were not always reported 
independently. Additionally, although age was reported in all studies, large age ranges 
prevented us from being able to assign the outcomes to a younger or older population 
for comparison. Statistical analyses were conducted using STATA software version 
13.0 (StataCorp, Texas, USA).  
 
Due to the nature of this systematic review, where data were compared before and 
after an intervention, the usual quality filters that apply to randomized controlled trials 
or observational studies could not be applied.  
 
3.4 Results 
As seen in Figure 1, 1,742 unique publications were retrieved from the 5 databases 
searched, with 74 full text publications being retrieved and assessed for eligibility 
after title and abstract screening. No further publications were found from screening 
the reference lists of those 74 articles. We found that 27 publications encompassing 
33 interventions matched our selection criteria. Some interventions examined more 
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than 1 muscle group or used more than 1 muscle strength assessment technique, with 
the results of these muscle groups or assessments being included as independent 
interventions. Eleven publications (12 interventions) reported the effect of weight loss 
on muscle strength as determined by 1RM, 9 publications (11 interventions) examined 
the effect of weight loss on muscle strength as determined by isokinetic 
dynamometry, primarily of the knee extensor or quadriceps muscles, 6 publications 
(10 interventions) examined the effects of weight loss on strength as determined by 
isometric dynamometry, largely of the leg extensor muscles, and 7 publications (11 
interventions) reported on handgrip strength, as shown in Figure 1.  
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Figure 1. Flow diagram for the process of publication selection, inclusion and 
exclusion from this systematic review and meta-analysis.  
 
3.4.1 Study Characteristics  
The publications included in this report are listed alphabetically in Table 1. Sample 
size varied from 5 to 71 men and / or women. The lowest mean age reported was 28 
years and the greatest was 70 years. Participants had a minimum and maximum 
baseline mean BMI of 27.8 kg/m2 and 37.2 kg/m2, respectively. Dietary interventions 
involved either VLED (13 interventions) or MER (20 interventions). No interventions 
administered a LED. The duration of dietary interventions ranged from 4 to 47 weeks 
for VLED and 8-24 weeks for MER, with a mode of 8 to 12 weeks for both VLED 
and MER. Two studies (31, 38) did not have a fixed duration of dietary intervention, 
rather, participants were prescribed a VLED and were required to lose a fixed 
percentage of their initial body weight, irrespective of how long it took to achieve.
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Table 1. Study characteristics for interventions investigating muscle strength 
First 
Author, 
year, 
reference 
Sample 
size, Sex 
and 
menopausa
l status of 
participant
s (percent 
female) 
Age 
– 
mean 
(SD) 
or 
rang
e 
Baseline 
BMI or 
weight – 
mean 
(SD) or 
selection 
criterion  
Duration 
and details 
of dietary 
weight loss 
interventio
n  
Weight 
change 
from 
baseline 
until the 
end of 
interventio
n – mean 
(SD)  
 
Baseline fat free 
mass (SD) 
[method of 
assessment and 
direction of 
change from 
baseline] 
 
Method/s of 
muscle 
strength 
assessment  
Muscles 
examined 
by muscle 
strength 
assessment/
s (and 
exercises 
used) 
[baseline 
strength 
(SD)]  
 
Primary 
outcome(s) 
Armamento
-Villareal 
2014 (43) 
26 
Men and 
women 
(65.0%) 
70.0 
(4.0) 
years 
37.2 (4.5) 
kg/m2 
24 weeks  
MER 
-9.7 (5.4) kg 
 
 
61.4 (13.0) kg 
[DXA ↓] 
Isokinetic 
dynamometr
y 
Knee 
extensors 
[71 (24) 
N/m] 
Knee flexors 
[50 (18) 
N/m] 
Muscle strength 
Body 
composition 
Bone mass 
 
Avila 2010 
(44) 
12 
Men and 
women 
(58.3%) 
67.4 
(4.8) 
years 
31.9 (3.4) 
kg/m2 
10 weeks  
MER 
-1.7 (0.9) kg 51.9 (9.0) kg [ADP 
↓] 
1RM Leg 
extensors 
[471 (39) N] 
Muscle strength 
Body 
composition 
Physical 
function  
 
Beavers 
2014 (45) 
24 
Men and 
women 
(87.5%) 
68.4 
(5.5) 
years 
36.0 (6.0) 
kg/m2 
12 weeks 
MER 
-7.8 (2.8) kg 51.9 (8.7) kg [DXA 
↓] 
Isokinetic 
dynamometr
y 
Handgrip 
strength 
Knee 
extensors 
[111 (28) 
N/m] 
Hand 
muscles 
[29.5 (9.0) 
Body 
composition 
Physical 
function 
Cardiometaboli
c capacity 
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kg] 
Bouchard 
2009 (30) 
11 
Women – 
post-
menopausal 
60.7 
(4.6) 
years 
31.9 (2.7) 
kg/m2 
12 weeks  
MER 
-4.0 (1.0) kg 39.2 (4.7) kg [DXA 
↓] 
Isometric 
dynamometr
y 
Leg 
extensors 
[104 (40) lb] 
Muscle strength 
Brinkworth 
2009 (37) 
32, men and 
women 
(71.9%) 
 
 
 
 
48.8 
(1.6) 
years 
33.7 (4.0) 
kg/m2 
8 weeks  
MER with 
low 
carbohydrat
e / high fat 
diet (C) 
 
 
 
-8.1 (2.3) kg 
 
 
51.4 (10.2) kg 
[DXA ↓] 
Isometric 
dynamometr
y 
Handgrip 
strength 
 
Knee 
extensors 
[577 (246) 
Nm]  
Hand 
muscles 
[39.7 (12.4) 
kg] 
 
Muscle strength 
Aerobic 
capacity 
Metabolic 
adaptions  
 
As above 28 
Men and 
women 
(53.6%) 
49.3 
(1.7) 
years 
33.7 (4.2) 
kg/m2 
8 weeks 
 MER with 
high 
carbohydrat
e / low fat 
diet (D) 
-6.7 (0.5) kg 
 
55.2 (11.8) kg 
[DXA ↓] 
Isometric 
dynamometr
y 
Handgrip 
strength 
Knee 
extensors 
[608 (250) 
Nm] 
Hand 
muscles 
[42.3 (12.7) 
kg] 
 
As above 
Campbell 
2009 (46) 
 
8 
Women – 
post-
menopausal 
67.0 
(2.8) 
years 
28.9 (3.4) 
kg/m2 
11 weeks  
MER 
-5.7 (0.3) kg 39.3 (3.7) kg [ADP 
↓] 
1RM Leg 
extensors 
(bilateral leg 
extension) 
[125 (23) 
Nm] 
Hamstring 
muscles 
(bilateral leg 
curl) [106 
(23) Nm] 
Body 
composition 
Protein 
metabolism 
Muscle protein 
synthesis rate  
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Leg muscles 
(Bilateral 
leg press) 
[909 (178) 
N] 
Chest, arm 
and 
abdominal 
muscles 
(bilateral 
chest press) 
253 (57) N] 
Chest, arm 
and 
abdominal 
muscles 
(bilateral 
arm pull) 
[315 (37) N] 
Davis 1990 
(38) 
5 
Women – 
pre-
menopausal 
 
 
 
 
33.0 
(3.1) 
years 
33.5 (3.4) 
kg/m2 
12 – 20 
weeks 
VLED with 
food (G) 
 
 
 
-17.2 (2.7) 
kg 
Not determined Isokinetic 
dynamometr
y 
Knee 
extensors 
[130 (5) 
N/m] 
Aerobic 
capacity 
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As above 5 
Women – 
pre-
menopausal 
28.0 
(5.3) 
years 
31.9 (3.8) 
kg/m2 
12 – 20 
weeks 
VLED with 
meal 
replacement 
formula 
shakes (H) 
-18.1 (4.2) 
kg 
Not determined  Isokinetic 
dynamometr
y 
Knee 
extensors 
[138 (10) 
N/m] 
As above 
Eston 1992 
(47) 
10 
Women 
23 – 
57 
years 
29.4 (SD 
could not 
be 
calculated
) kg/m2 
6 weeks  
VLED 
-11.5 (2.0) 
kg 
50.6 (5.4) kg [BIA 
↓] 
Isokinetic 
dynamometr
y 
Quadriceps 
[138 (19) 
N/m] 
Hamstrings 
[73.4 (14) 
N/m] 
Body 
composition 
Cardiometaboli
c capacity 
Figueroa 
2013 (48) 
13 
Women – 
post-
menopausal 
54.0 
(3.6) 
years 
34.8 (4.3) 
kg/m2 
12 weeks  
MER 
-5.6 (0.7) kg 43.6 (5.8) kg [DXA 
↓] 
8RM Leg muscles 
[118 (29) 
kg] 
Body 
composition 
Pulse-wave 
velocity 
Arterial 
stiffness  
 
Frimel 2008 
(12) 
15 
Men and 
women 
(60.0%) 
70.3 
(4.8) 
years 
36.9 (4.9) 
kg/m2 
24 weeks 
VLED 
-10.7 (4.5) 
kg 
59.8 (13.2) kg 
[DXA ↓] 
1RM  Shoulder 
and biceps 
(biceps curl) 
[Data not 
available] 
Back, chest 
and arm 
muscles 
(seated row) 
[Data not 
available] 
Chest, arm 
Muscle strength  
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and 
abdominal 
muscles 
(bench 
press) [Data 
not 
available]  
Leg muscles 
(leg press) 
[Data not 
available]  
Knee flexors 
[Data not 
available]  
Knee 
extensors 
[Data not 
available]  
Geliebter 
1997 (49) 
22 
Men and 
women 
(63.6%) 
36.0 
(8.0) 
years 
≥ 25.0 
kg/m2 
8 weeks  
MER 
-9.5 (3.1) kg 57.0 (12.2) kg 
[BIA ↓] 
Handgrip 
strength 
Hand 
muscles  
[34.5 (12.0) 
kg] 
 
Body 
composition 
Metabolic 
capacity 
Hue 2008 
(31) 
17 
Men 
36.9 
(7.7) 
years 
34.0 (4.7) 
kg/m2 
15 – 47 
weeks 
VLED 
-11.8 (0.8) 
kg 
Not determined Isometric 
dynamometr
y 
Quadriceps 
[795 (175) 
N] 
Muscle strength  
Kraemer 
1997 (32) 
8 
Women 
34.6 
(10.2
) 
years 
27.3 (3.1) 
kg/m2 
12 weeks 
 MER  
-6.2 (SD not 
reported) kg 
 
43.8 (5.3) kg 
[Hydrodensitometr
y ↔] 
 
1RM  Chest, arm 
and 
abdominal 
muscles 
(bench 
press) [38 
(5) kg] 
Leg and 
Physical 
capacity 
Physiological 
adaptions 
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gluteal 
muscles 
(squat) [72 
(30) kg] 
Krotkiewski 
1990 (50) 
25 
Women 
40.1 
(14.6
) 
years 
36.9 (6.0) 
kg/m2 
 
4 weeks  
VLED 
-8.6 (4.5) kg 60.2 (10.0) kg 
[Total body 
potassium content 
↓] 
Isokinetic 
dynamometr
y 
Knee 
extensors 
[data not 
available]  
Muscle strength 
Muscle 
morphology 
Larson-
Meyer 2009 
(34) 
12 
Men and 
women 
(50.0%) 
39.0 
(5.0) 
years 
27.8 (1.4) 
kg/m2 
24 weeks  
MER 
-8.3 (2.8) kg 5.8 (2.1) kg 
[DXA ↓] 
Isokinetic 
dynamometr
y 
Knee 
extensors 
[152 (16) 
N/m] 
Knee flexors 
[67 (11) 
N/m] 
Body 
composition 
Cardiometaboli
c capacity 
Marks 1994 
(35) 
10 
Women 
38.3 
(7.8) 
years 
30.1 (3.2) 
kg/m2 
20 weeks  
MER 
-3.7 (4.4) kg 47.4 (5.9) %    
[Hydrodensitometr
y ↔] 
 
1RM Chest, arm 
and 
abdominal 
muscles 
(chest press) 
[42 (13) kg] 
Leg extensor 
[56 (13) kg] 
Shoulder 
and biceps 
muscles 
(arm curl) 
[13 (4) kg] 
Shoulder 
and triceps 
muscles 
(triceps 
extension) 
Muscle strength 
Body 
composition 
Physical 
capacity 
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[9 (2) kg] 
Messier 
2009 (51) 
71 
Women – 
post-
menopausal 
58.0 
(4.7) 
years 
32.2 (4.6) 
kg/m2 
24 weeks 
VLED 
-5.2 (19.4) 
kg 
45.4 (7.2) kg [DXA 
↓] 
1RM  Lower body 
[147 (39) 
kg] 
Psychosocial 
function 
Napoli 2014 
(52) 
26 
Men and 
women 
(65.0%) 
70.0 
(4.0) 
years 
37.2 (4.5) 
kg/m2 
24 weeks  
MER 
-9.7 (5.4) kg 61.4 (13.0) kg 
[DXA ↓] 
1RM Upper body 
[106 (45) 
kg] 
Lower body 
[170 (55) 
kg] 
Psychological 
function 
Health quality 
Pargman 
1967 (53) 
25 
Women 
30 – 
50 
years 
≥ 30.0 
kg/m2 
12 weeks 
VLED 
-16.3 (SD 
not 
reported) kg 
Not determined Isokinetic 
dynamometr
y 
Handgrip 
strength 
 
Knee 
extensors 
[41 (9) lb] 
Elbow 
extensors 
[25 (7) lb] 
Hand 
muscles 
[36.8 (5.2) 
lb] 
Muscle strength  
Pavlou 1985 
(54) 
41 
Men 
46.1 
(8.3) 
years 
100.8 
(14.1) kg 
8 weeks  
VLED 
-9.2 (1.9) kg 62.2 (9.6) kg Total 
body potassium  
Isokinetic 
dynamometr
y 
Quadriceps 
[Data not 
available]  
Muscle strength 
Body 
composition 
Metabolic 
capacity  
Pronk 1992 
(55) 
40 
Women 
42.6 
(10.5
) 
years 
104.7 
(18.2) 
kg 
22 weeks  
VLED 
-20.8 (5.5) 
kg 
55.0 (7.4) kg 
[Hydrodensitometr
y ↓] 
1RM Chest, arm 
and 
abdominal 
muscles 
(bench 
press) [28 
(6) kg] 
Chest, arm 
Muscle strength 
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and 
abdominal 
muscles 
(lateral pull 
down) [34 
(7) kg] 
Knee 
extensors 
[29 (11) kg] 
Knee flexors 
[18 (6) kg] 
Scott 1992 
(39) 
19 
Women – 
pre-
menopausal 
 
 
 
38.0 
(6.0) 
years 
28.9 (2.3) 
kg/m2 
8 weeks  
MER with 
high fat diet 
(E) 
 
 
 
-7.4 (10.9) 
kg 
 
49.7 (4.9) kg 
[Hydrodensitometr
y ↔] 
1RM 
Isokinetic 
dynamometr
y 
Chest, arm 
and 
abdominal 
muscles 
(bench 
press) [36 
(5) kg] 
Leg muscles 
(leg press) 
[93 (15) kg] 
Knee 
extensors 
[135 (23) 
N/m] 
Knee flexors 
[77 (14) 
N/m]  
Muscle strength 
Physical 
capacity 
Metabolic 
capacity 
As above 17 
Women – 
pre-
menopausal 
37.0 
(5.0) 
years 
30.7 (2.5) 
kg/m2 
8 weeks  
MER with 
high 
carbohydrat
e diet (F) 
-6.5 (11.1) 
kg 
50.9 (5.0) kg 
[Hydrodensitometr
y ↔] 
1RM 
Isokinetic 
dynamometr
y 
Chest, arm 
and 
abdominal 
muscles 
(bench 
press) [39 
As above  
Muscle strength change with dietary weight loss  Chapter 3 
 
 81 
(7) kg] 
Leg muscles 
(leg press) 
[98 (14) kg] 
Knee 
extensors 
[137 (18) 
N/m] 
Knee flexors 
[80 (12) 
N/m] 
Siervo 2012 
(56) 
21 
Men and 
women 
(80.9%) 
56.9 
(9.7) 
years 
36.4 (5.7) 
kg/m2 
15 weeks  
MER 
-9.0 (22.5) 
kg 
54.5  (13.8) kg 
[BIA ↓]  
Handgrip 
strength 
Hand 
muscles 
[28.2 (11.4) 
kg] 
Psychological 
function 
Uusi-Rasi 
2009 (41) 
37 
Women – 
pre-
menopausal 
42.0 
(7.0) 
years 
35.2 (5.2) 
kg/m2 
12 weeks  
MER 
 
-4.3 (4.5)) 
kg 
49.2 (8.6) kg [DXA 
↔] 
Isometric 
dynamometr
y 
Leg 
extensors 
[24 (5) 
N/kg] 
Muscle strength 
Body 
composition 
Bone mass 
Uusi-Rasi 
2010 (40) 
20 
Women – 
pre-
menopausal 
 
 
 
 
42.1 
(3.7) 
years 
33.3 (3.3) 
kg/m2 
12 weeks 
VLED with 
large weight 
loss (-19.2 
to -13.5% of 
body 
weight) (I)  
 
 
 
-14.3 (3.7) 
kg 
 
 
47.9 (6.1) kg [DXA 
↔] 
Isometric 
dynamometr
y 
Handgrip 
strength 
 
Leg 
extensors 
[28 (12) 
N/kg] 
Hand 
muscles 
[36.8 (4.3) 
kg] 
Muscle strength 
Body 
composition 
Bone mass 
Bone 
biomarkers 
As above 21 
Women – 
pre-
menopausal 
39.2 
(5.6) 
years 
33.1 (4.5) 
kg/m2 
12 weeks 
VLED with 
medium 
weight loss 
(-13.4 to -
-9.7 (4.8) kg 45.5 (7.0) kg [DXA 
↔] 
Isometric 
dynamometr
y 
Handgrip 
strength 
Leg 
extensors 
[24 (4) 
N/kg] 
Hand 
As above 
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8.2% of 
body 
weight) (J) 
muscles 
[34.8 (4.5) 
kg] 
As above 21 
Women – 
pre-
menopausal 
39.3 
(5.7) 
years 
34.4 (5.5) 
kg/m2 
12 weeks 
VLED with 
low weight 
loss (-8.2 to 
-2.1% of 
body 
weight) (K) 
-5.6 (4.5) kg 47.3 (5.5) kg [DXA 
↔] 
Isometric 
dynamometr
y 
Handgrip 
strength 
Leg 
extensors 
[26 (6) 
N/kg] 
Hand 
muscles 
[36.3 (4.7) 
kg] 
As above  
Villareal 
2011 (36) 
26 
Men and 
women 
(65.0%) 
70.0 
(4.0) 
years 
37.2 (4.5) 
kg/m2 
24 weeks  
MER 
-9.0 (5.4) kg 61.4 (13.0) kg 
[DXA ↓] 
1RM Shoulder 
and biceps 
muscles 
(bicep curls) 
Chest, arm 
and 
abdominal 
muscles 
(bench 
press) 
Back, chest 
and arm 
muscles 
(seated row) 
Knee 
extensors 
Knee flexors 
Leg muscles 
(leg press) – 
Reported as 
total 1RM 
[607 (213) 
lb] 
Physical 
capacity 
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Wycherley 
2013 (42) 
21 
Men 
 
 
47.7 
(8.0) 
years 
27 - 40 
kg/m2  
12 weeks  
MER with 
high protein 
diet (A) 
 
 
 
-10.7 (5.3) 
kg 
70.5 (7.0) kg [DXA 
↓] 
Isometric 
dynamometr
y 
Handgrip 
strength 
Knee 
extensors 
[210 (52) 
Nm] 
Hand 
muscles 
[50.0 (12.0) 
kg] 
Muscle strength 
Aerobic 
capacity 
As above 21 
Men 
45.9 
(8.1) 
years 
27 - 40 
kg/m2  
12 weeks  
MER with 
normal 
protein diet 
(B) 
-8.7 (3.5) kg 68.1 (8.5) kg [DXA 
↓] 
Isometric 
dynamometr
y 
Handgrip 
strength 
Knee 
extensors 
[188 (41) 
Nm] 
Hand 
muscles 
[55.1 (6.6) 
kg] 
As above 
 
↓: fat free mass is statistically significantly decreased; ↑: statistically significantly increased; or ↔: not statistically significantly different from 
baseline. ADP, Air displacement plethysmography; BIA, bioelectrical impedance analysis; BMI, body mass index; DXA, dual energy X-ray 
absorptiometry; MER, moderate energy restriction; 1RM, one repetition max; 8RM, eight repetition maximum (rather than a weight being moved a 
maximum of once (as in 1RM), it is moved a maximum of 8 times); SD, standard deviation; VLED, very low energy diet. 
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3.4.2 One repetition maximum strength testing 
Of the 11 publications (12 interventions) that measured muscle strength via 1RM testing, a variety 
of muscle groups from both the upper and lower body were tested in response to a variety of dietary 
interventions, as shown in Table 1. Because 8 out of 11 publications (12, 32, 35, 36, 39, 46, 52, 55) 
investigated more than one particular muscle group through varying exercise movements, such as 
knee extension, and because different muscle groups may have opposing responses to a particular 
intervention, it was not appropriate to combine all interventions into a meta-analysis and so the 
results were analyzed qualitatively.  
 
Despite variations in muscle groups examined and dietary interventions, the results were consistent, 
in that weight loss did not induce significant changes in muscle strength as assessed by 1RM, with 
the exception of 1 intervention (52) involving a diet of MER which found that upper body strength 
was significantly decreased, whilst lower body strength was significantly increased relative to 
baseline, albeit muscle strength was not a primary outcome in that study. Some studies reported 
non-significant trends in changes in muscle strength with diet-induced weight loss, as assessed by 
1RM testing. Specifically, two interventions, both of which prescribed MER, reported non-
significant decreases in chest, arm (35) and lower body (35, 51) strength. In contrast, non-
significant increases in triceps (35) and total body (36) strength were noted in 2 interventions with 
participants also on a diet involving MER. Only 1 intervention (55) investigating muscle strength 
through 1RM administered a VLED, but no trends or significant changes in muscle strength were 
found in that study. Taken together, it is evident that diet-induced weight loss does not affect 
muscle strength as assessed by 1RM testing, despite muscle strength being the primary outcome in 
7 of the 11 publications that measured muscle strength with this method (12, 32, 35, 36, 39, 44, 55). 
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3.4.3 Isokinetic dynamometry  
Of the 9 publications (11 interventions) that measured muscle strength via isokinetic dynamometry, 
7 investigated knee extensor muscles (34, 38, 39, 43, 45, 50, 53), 3 of these also investigated knee 
flexor muscles (34, 39, 43), and 3 publications examined the effect of weight loss on quadriceps 
muscles (47, 54), hamstring muscles (47) or elbow flexion (53). 
 
A meta-analysis was conducted on 5 of the 7 publications that examined knee extensor muscle 
strength as determined by isokinetic dynamometry (34, 38, 39, 43, 45). The 2 remaining 
publications (2 interventions) that examined knee extensor strength (50, 53) were not included in 
the meta-analysis because the units of measurement – Nm (50) and tensiometer units (53) – were 
different from that of the meta-analyzed studies (N/m), and conversion was not possible. These 
studies were analyzed qualitatively as described below. The 5 meta-analyzed studies were 
conducted in a total of 108 participants, in which body weight was significantly decreased by the 
intervention (-9.2 [95% confidence interval: -13.6, -4.7] kg, P < 0.001). As shown in Figure 2, this 
weight loss intervention resulted in a significant decrease in knee extensor strength (– 9.0 [-13.8, -
4.1] N/m, P < 0.001), with no significant heterogeneity present (P = 0.087). This decrease in knee 
extensor strength represents a 7.5% decrease from the mean baseline value of 125 ± 18 N/m, as 
calculated using random effects meta-analysis to obtain pooled changes in muscle strength as a 
percent of baseline. When interventions were analyzed according to the degree of energy restriction, 
significant decreases in body weight and isokinetic knee extensor strength were apparent for both 
MER and VLED interventions. Indeed, for the 98 participants on the 5 MER interventions from 4 
publications (34, 39, 43, 45), significant decreases in body weight (-6.2 [-9.0, -3.5] kg, P < 0.001) 
and isokinetic knee extensor strength (- 5.5 [-8.7, -2.2] N/m, P < 0.001) were apparent, representing 
a pooled 5.2% decrease from the baseline strength value of 121 ± 22 N/m. For the 10 participants 
on 2 VLED interventions from 1 publication (38), significant reductions in body weight (-17.4 [-
18.3, -16.6] kg, P < 0.001) and isokinetic knee extensor strength (-14.7 [-20.8, -8.7] N/m, P < 
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0.001) were also apparent, representing a pooled 13.1% decrease from the baseline strength value of 
134 ± 8 N/m. Of the 2 publications that were excluded from the meta-analysis and analyzed 
qualitatively instead, knee extensor strength significantly decreased in 1 publication, which 
administered a 4-week VLED (50), while there was no significant change reported in the other 
publication, which also administered a VLED (12 weeks in this instance) (53). This discrepancy 
may be due to the latter publication (53) being published in 1967 and using different equipment.  
 
 
Figure 2. Forest plot of change in knee extensor strength (as determined by isokinetic 
dynamometry) from baseline until the end of dietary weight loss interventions. The letters in 
parentheses to the right of each study are used to distinguish whether the intervention involved 
moderate energy restriction (MER) or a very low energy diet (VLED), and to distinguish different 
dietary interventions from the same publication, with details of all corresponding dietary 
interventions listed in Table 1. Plotted values (and the numbers at right) represent the actual change 
in knee extensor strength in N/m, with 95% confidence intervals (CI) illustrated by the error bars 
(or the numbers in parentheses at right). Mean ± SD of knee extensor strength at baseline was 125 ± 
18 N/m for all studies overall, 121 ± 22 N/m for MER and 134 ± 8 N/m for VLED. I2 indicates the 
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percentage heterogeneity. 
 
Those publications that used isokinetic dynamometry but did not examine knee extensor strength 
were analyzed qualitatively. Four publications (5 interventions) administering a diet involving MER 
showed no significant changes in knee flexion (34, 39, 43) or quadriceps strength (54) as examined 
via isokinetic dynamometry, which is different from our findings in the meta-analysis of knee 
extensor strength. A total of 2 publications investigated isokinetic muscle strength after a VLED 
intervention (47, 53). One publication involving VLED showed a significant decrease in quadriceps 
strength (47), albeit there were no significant changes in elbow flexion (53) or, as measured in a 
separate publication, hamstring strength (47), in response to VLED and as assessed via isokinetic 
dynamometry.  
 
Taking the results of our quantitative and qualitative analyses together, diets involving both MER 
and VLED have a negative effect on knee extensor strength, and VLED may also have a negative 
effect on quadriceps strength as examined by isokinetic dynamometry, whilst neither diet seems to 
have any significant effect on knee or elbow flexion strength despite significant weight loss.  
 
3.4.4 Isometric dynamometry  
Muscle strength was assessed via isometric dynamometry in 6 publications (30, 31, 37, 40-42), 
which involved 10 interventions. As isometric dynamometry data from these interventions were 
collected using different techniques (involving differences in measurement parameters such as 
extension angles), actual changes could not be pooled using meta-analysis. Thus, these 
interventions were examined qualitatively. 
 
We separated interventions according to the severity of energy restriction. Six of the 10 
interventions from 4 publications (30, 37, 41, 42) involved MER, whilst the 4 remaining 
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interventions from 2 publications (31, 40) assessed the effect of VLED on muscle strength as 
determined by isometric dynamometry. Of the 6 MER interventions, a significant decrease in leg 
extension strength was found with 1 such intervention (30), while another one induced a significant 
increase in leg extension strength (41). The other 4 MER interventions examined isometric knee 
extensor strength. Two such interventions (37) found a tendency to increase, whilst the other 2 
interventions from 1 publication (42) found significant increases after MER in isometric knee 
extensor strength. Similar to MER, mixed results were found in the 4 interventions inducing weight 
loss via VLED. One intervention investigating quadriceps strength in participants on a VLED found 
a significant decrease in strength as assessed by isometric dynamometry (31), consistent with the 
results reported above for knee extensor strength and quadriceps strength as assessed using 
isokinetic dynamometry. In contrast, 2 interventions involving VLED found no significant 
differences in leg extension strength (40), whilst a further VLED intervention from the same 
publication found a significant increase in leg extension strength (40). Interestingly, this latter 
VLED intervention also resulted in a greater percentage body weight loss compared to the other 2 
VLED interventions where no significant change in leg extension strength was observed. From 
these overall results (2 interventions inducing significant decreases in muscle strength, 4 inducing 
significant increases, and 4 inducing non-significant changes), both MER diets and VLED induce 
unclear effects on muscle strength as assessed by isometric dynamometry of various leg muscles, 
with no sound conclusion possible from the available data.  
 
3.4.5 Handgrip strength 
There were 7 publications (11 interventions) that investigated changes in handgrip strength in 
response to diet-induced weight loss (37, 40, 42, 45, 49, 53, 56). Of these, 1 publication (1 
intervention) (53) was excluded from the meta-analysis, because it used a cable tension 
dynamometer rather than the hydraulic dynamometer that was used in the other publications, and 
the unit of measurement (tensiometer units) could not be converted into kg, so that intervention was 
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analyzed qualitatively. Our meta-analysis was thus conducted on 10 interventions in a total of 231 
participants. In these, body weight was significantly decreased by the intervention (-8.8 [-10.2, -7.4] 
kg, P < 0.001), and overall handgrip strength decreased, but this latter effect was not statistically 
significant (-1.7 [-3.6, 0.1] kg, P = 0.070) (Figure 3). This change in handgrip strength represents a 
-3.6% change from the mean baseline value 39 ± 9 kg, as calculated using random effects meta-
analysis to obtain pooled changes in muscle strength as a percent of baseline. Significant 
heterogeneity was found (I2 = 83.9%, P < 0.001), and so we questioned whether differences in 
results occurred due to differences in dietary interventions. Of the 10 interventions included in our 
meta-analysis of handgrip strength, 7 prescribed MER in a total of 169 participants (with a duration 
of 8 weeks in 3 interventions, 12 weeks in 3 interventions, and 15 weeks in 1 intervention), and 3 
prescribed VLED in a total of 62 participants (all with a duration of 12 weeks). MER resulted in a 
significant decrease in handgrip strength (-2.4 [-4.8, -0.0] kg, P = 0.046), representing a pooled 
4.6% decrease from the mean baseline value of 40 ± 8 kg, in conjunction with significant weight 
loss (-7.6 [-8.3, -6.9] kg, P < 0.001). In contrast, VLED induced no significant change from 
baseline in handgrip strength (-0.4 [-2.0, 1.2] kg, P = 0.610), representing a pooled -1.1% change 
from the mean baseline value of 36 ± 4 kg, despite significant weight loss (-9.0 [-15.0, -3.0] kg, P = 
0.003). This difference between MER and VLED in terms of effects on handgrip strength is 
unlikely due to differences in diet duration, given the similar duration of interventions. These 
findings are in contrast to the results from our meta-analysis of knee extensor strength as 
determined by isokinetic dynamometry, where significant decreases were found with both MER and 
VLED interventions. The publication that was not included in our meta-analysis of handgrip 
strength administered a VLED in 25 participants (53). The results of that publication agree with the 
results of this meta-analysis, in that no significant effect of VLED on handgrip strength was 
detected. 
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Figure 3. Forest plot of change in handgrip strength from baseline until the end of dietary 
weight loss interventions. The letter in parentheses to the right of each study is used to distinguish 
whether the intervention involved moderate energy restriction (MER) or a very low energy diet 
(VLED), and to distinguish different dietary interventions from the same publication, with details of 
all corresponding dietary interventions listed in Table 1. Plotted values (and the numbers at right) 
represent the actual change in handgrip strength in kg with 95% confidence intervals (CI) illustrated 
by the error bars (or the numbers in parentheses at right). Mean ± SD of handgrip strength at 
baseline was 39  ± 9 kg for all studies overall, 40 ± 8 kg for MER and 36 ± 4 kg for VLED. I2 
indicates the percentage heterogeneity.  
 
3.4.6 Relationship between changes in muscle strength with changes in fat free mass 
As fat free mass is a known predictor of muscle strength (13, 14), we hypothesized that a decrease 
in fat free mass may contribute to reduced muscle strength with diet-induced weight loss. Thus, 
changes from baseline in fat free mass were meta-analysed in those studies that investigated knee 
extensor strength (via isokinetic dynamometry) and handgrip strength.  
Muscle strength change with dietary weight loss Chapter 3 
 
 91 
 
For studies investigating knee extensor strength via isokinetic dynamometry, fat free mass was only 
available for meta-analysis from participants that underwent MER. This is because the 2 
interventions from the 1 study (38) that examined effects of VLED did not investigate fat free mass. 
In these studies, MER resulted in a significant decrease from baseline in fat free mass (-2.0 [-3.6, -
0.4] kg, P < 0.05), echoing the significant decrease in knee extensor strength determined by 
isokinetic dynamometry, as reported above. 
 
For participants undergoing handgrip strength testing for studies included in our meta-analysis, fat 
free mass was significantly decreased from baseline after diet-induced weight loss (-1.9 [-3.3, -0.5] 
kg, P < 0.01). The degree of energy restriction influenced whether the decrease in fat free mass was 
significant. Indeed, participants on MER lost a significant amount of fat free mass (-2.2 [-4.0, -0.4] 
kg, P < 0.05), in contrast to those on VLED that did not (-1.5 [-3.6, 0.6] kg, P = 0.153). These 
findings for fat free mass echo the significant decrease in handgrip strength seen with MER, and the 
non-significant change in handgrip strength seen with VLED, reported above.  
 
3.5 Discussion  
This systematic review and meta-analysis showed that diet-induced weight loss in adults that are 
overweight or obese resulted in a significant decrease from baseline in knee extensor strength as 
assessed by isokinetic dynamometry, with significant decreases found for participants on either 
MER or VLED, and a non-significant decrease in handgrip strength, with significant heterogeneity 
in results. This heterogeneity may have been due to diet type, because there were significant 
decreases in handgrip strength after MER but not VLED. No significant effects of diet-induced 
weight loss were detected with 1RM strength testing, including 3 interventions involving a VLED 
(12, 51, 55), with the exception of 1 MER intervention (52) that observed a significant decrease in 
upper body strength and a significant increase in lower body strength. Qualitative assessment of the 
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7 and 10 interventions that assessed strength of other muscles by isokinetic and isometric 
dynamometry, respectively, revealed mixed results (decreases, no significant changes or increases 
from baseline), with no clear distinction between effects of MER versus VLED. Indeed, there were 
studies involving MER inducing a significant decrease (30) or increase (41) in leg extension 
strength and a significant increase in knee extensor strength (42), with studies administering VLED 
inducing a significant decrease in quadriceps strength (31) or a significant increase in leg extension 
strength (40). This lack of clear, statistically significant effect of diet induced weight loss on muscle 
strength may be due to a lack of evidence either way, rather than lack of a true underlying effect. 
Given the findings from our meta-analyses, we thus conclude that diet-induced weight loss may 
reduce muscle strength, but further research would be required to clarify any such effect and the 
impact of different degrees of energy restriction.  
 
Our results suggest that the loss of knee extensor and handgrip strength with diet-induced weight 
loss occurs at 16-33 times the rate of normal age-associated loss of muscle strength. Knee extensor 
strength, as assessed by isokinetic dynamometry, was reduced by 9.0 N/m (7.5%) from baseline 
over a 12-24-week period in all diets combined (5.2% with MER, 13.1% with VLED), whilst 
handgrip strength was reduced by 2.4 kg (4.6%) from baseline over an 8-15-week period with MER 
but not VLED. Considering that muscle strength is reduced by 8-10% per decade beyond the age of 
40 (16), it appears that a diet of less than 6 months in duration induces strength losses equivalent to 
4.6-16.4 years of normal ageing. A 5 kg reduction in handgrip strength over a 4-year period was 
associated with an elevated hazard ratio of all-cause mortality, cardiovascular mortality, non-
cardiovascular mortality, myocardial infarction and stroke (hazard ratio 1.07 to 1.17) (23). 
Therefore, our observed decreases in muscle strength are a potential cause for concern, especially 
when considering that many individuals undergo dietary weight loss interventions of 6 months in 
duration or longer, or undergo repeated dietary weight loss interventions as a means of long-term 
weight management. However, given the consistent evidence for health benefits of losing at least 3-
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15% of body weight (57), the current findings should not be used to discourage weight loss in 
people with overweight or obesity. Rather, they indicate a need for interventions that attenuate 
possible strength reductions during diet-induced weight loss. Such interventions would likely 
include weight training or other forms of exercise that have been shown to increase muscle strength 
despite concurrent weight loss (12, 33, 44, 48, 55).  
 
From our results, we believe that isokinetic dynamometry and handgrip strength testing may 
provide more informative results about changes in muscle strength in response to diet-induced 
weight loss in comparison to 1RM testing and isometric dynamometry. Only 1 of 12 interventions 
from 11 publications using the 1RM technique showed significant changes in muscle strength, and 
that study showed contrasting results depending on the muscle group being tested, and moreover, 
muscle strength was not a primary outcome in that study (52). Contrastingly, 5 of the 11 
publications that investigated 1RM had muscle strength as the primary outcome (12, 35, 39, 44, 55), 
and those studies did not find statistically significant changes in muscle strength. Reasons for the 
lack of significant results from 1RM testing may be due to an apparent lack of set speed of 
contraction or positioning of the subject when performing the tests, with both of these factors 
influencing the results (58). Studies that used isometric dynamometry to measure muscle strength 
showed inconsistent results. Therefore, 1RM and isometric dynamometry may not be sensitive 
enough to determine potential changes in muscle strength in response to diet-induced weight loss, in 
contrast to isokinetic dynamometry and handgrip strength testing. Different techniques vary in their 
ability to detect changes in strength in response to a 12-week strength-training program in men (59), 
with 1RM testing registering the largest increase, followed by isokinetic dynamometry and lastly, 
with the least difference from baseline detected, isometric dynamometry. Despite the apparent 
sensitivity of 1RM testing for detecting increases in muscle strength, isokinetic dynamometry has 
been considered as the reference method for muscle strength testing (25, 60-63), providing valid 
and reliable results compared to other forms of muscle strength assessment (64-66). However, 
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recent studies have revealed that handgrip strength, as measured with handheld dynamometers, 
provides a greater validity and reliability of results when compared with 1RM or isokinetic 
dynamometry (67, 68).  Moreover, handgrip strength testing is a more feasible method of measuring 
muscle strength than isokinetic dynamometry, due to cost and logistics. Given these practical 
considerations, and given that handgrip strength can be representative of upper body strength (69) 
and lower extremity muscle power (70, 71), as well as being associated with nutritional status and a 
predictor of health outcomes (23, 72, 73), handgrip strength testing will likely be a useful and 
clinically relevant technique for assessing changes in muscle strength in response to diet-induced 
weight loss.  
 
This systematic review has highlighted numerous limitations in studies conducted to date. 14 of the 
33 interventions included in this review had very small sample sizes of less than 20 participants (12, 
30-32, 34, 35, 38, 39, 44, 46-48), with a further 14 interventions having small sample sizes of only 
20-30 participants (36, 37, 40, 42, 43, 45, 49, 50, 52, 53, 56). 4 interventions had moderate sample 
sizes of 30-41 participants (37, 41, 54, 55), and only 1 intervention (51) investigating muscle 
strength via 1RM testing had a large sample size (71 participants), albeit that study found no 
significant results. Additionally, muscle strength was a primary outcome in only 15 (12, 30, 31, 35, 
37, 39-44, 50, 53-55) of the 27 publications included in this review. Of these 15 publications, 8 
found significant changes in muscle strength in varying muscle groups (30, 31, 37, 39-42, 50); 9 
muscle groups showed significant decreases in strength (30, 37, 39, 40, 42, 50, 74), 30 showed no 
significant change (12, 35, 37, 40, 43, 44, 53-55), and 3 muscle groups showed significant increases 
in strength (41, 42). Therefore, the lack of clarity of results in the reviewed work may be a 
consequence of small cohorts, as well as muscle strength not being a primary outcome in 
approximately half of the 27 publications. An additional limitation of the reviewed publications was 
that only 4 publications (36, 43, 47, 52) investigated muscle strength at a time point subsequent to 
the end of the dietary intervention, one of which was only 1 week post VLED (47), whilst the other 
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3 publications (36, 43, 52) investigated muscle strength 6 months after completion of the dietary 
intervention. Long-term follow up studies are required to determine whether any changes in muscle 
strength in response to severe or moderate energy restriction are temporary, as in two current trials 
by our team (74, 75), as well as the possible long-term implications for balance and performing 
activities of daily living (46). 
 
In summary, isokinetic dynamometry of knee extensors revealed significant decreases in muscle 
strength in adults that were overweight or obese after interventions involving either MER or VLED, 
and handgrip strength testing showed overall trends for decreases in muscle strength, with 
significant reductions being seen with interventions involving MER but not VLED. Neither 1RM 
testing nor isometric dynamometry showed any clear effect of diet-induced weight loss on muscle 
strength, regardless of whether a VLED or MER was prescribed. While sample sizes were small, 
and approximately half of the reviewed publications were not powered to detect changes in muscle 
strength, these findings nonetheless indicate that diet-induced weight loss could have adverse 
effects on muscle strength. Given that muscle strength is an important predictor of mobility and 
mortality (14, 22, 23), and given that our population is getting heavier, with diet-induced weight 
loss being an important treatment option that helps to lessen numerous co-morbidities (2-4, 57, 76), 
further research is warranted to ensure that different types of diet-induced weight loss do not 
inadvertently lead to reduced muscle strength in a way that adversely impacts on long-term health.  
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Chapter 4: General Discussion 
 
Due to the increasingly obese population and consequently an increase in the number 
of individuals undergoing dietary interventions for weight loss, two systematic 
reviews and meta-analyses were conducted in this thesis in order to elucidate the 
effects of diet-induced weight loss on bone and muscle strength, markers of disease 
and health status.  
 
In summary, Chapter 2 illustrated that BMD decreased with diet-induced weight loss 
in overweight and obese individuals. Total Hip BMD significantly decreased from 
baseline in interventions of durations 6 to 24 months, as well as in an analysis of all 
interventions of varying durations. Whilst lumbar spine and total body BMD showed 
no significant changes from baseline with weight loss when all durations of dietary 
interventions were grouped, a significant decrease in total body BMD was found after 
dietary weight loss interventions of 6 months in duration. However, the lumbar spine 
and total body are not the gold standard sites when translating changes in BMD to risk 
of osteoporosis and fractures (1, 2). The reason for this, as outlined in Chapter 2, is 
because the lumbar spine is prone to greater measurement error with DXA (3). 
Moreover, the spine is susceptible to calcification that can lead to inaccurate BMD 
readings (4, 5). Thus, total hip BMD measurements are more reliable and accurate 
than the lumbar spine or total body BMD at estimating osteoporosis and fracture risk 
(6-8). Bone formation markers, serum P1NP and serum osteocalcin concentrations, 
showed no overall change in response to diet-induced weight loss, except for a 
significant increase in serum osteocalcin concentration with dietary interventions 
lasting 3 months. Bone markers of resorption, serum CTX as well as serum and 
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urinary NTX concentrations, showed overall tendencies to increase in response to 
diet-induced weight loss. Serum CTX, when reported in nmol/L, showed significant 
increases whilst, when reported in µg/L, a significant increase was found at 3 months, 
with no significant changes from baseline at 2, 6, 12 or 24 months. However, the 
more commonly reported unit for serum-CTX is µg/L, with reference ranges for 
serum CTX being reported in µg/L rather than mmol/L (9, 10), and thus, those results 
reported in µg/L are of greater interest. Future measurements of serum CTX should be 
reported in µg/L so that comparisons between interventions can be drawn. Serum and 
urinary concentrations of NTX, a marker of bone resorption, showed an overall trend 
to increase with diet-induced weight loss, with a significant increase only occurring 
with dietary interventions of 2 months for serum NTX. Taken together, these changes 
in bone turnover markers (increases in markers of bone formation and resorption) 
compliment the negative change seen in total hip BMD, suggesting an overall 
catabolic effect of diet-induced weight loss on bone. These results further support the 
need for bone turnover marker measurements, as they are able to detect changes 
occurring in bone in the short term; 2-3 months compared to BMD measurements, 
where significant changes were registered only after 6 months. Detecting changes in 
bone earlier rather than later is important, as with the screening for other diseases, 
because it allows for prompt treatment to be initiated as required.  
 
Changes in muscle strength following a dietary weight loss intervention in overweight 
and obese populations were analyzed in Chapter 3 using one of 4 different techniques: 
1RM, isokinetic dynamometry, isometric dynamometry and handgrip strength testing. 
Muscle strength as assessed by 1RM and isometric dynamometry were analysed 
qualitatively and showed mixed findings for both of prescribed dietary interventions. 
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Only one study, administering an intervention involving MER, found a significant 
change in muscle strength as measured by 1RM in an overweight and obese cohort. A 
significant decrease in upper body strength and a significant increase in lower body 
strength as assessed by 1RM was shown in that study. On the other hand, isometric 
dynamometry demonstrated inconsistent results with 4 significant increases in muscle 
strength being reported, 2 significant decreases, 2 tendencies to increase and 2 non 
significant changes in muscle strength being found across varying muscle groups, 
with no clear distinction between the effects of MER or VLED dietary interventions. 
Isokinetic knee extensor strength and handgrip strength changes were analysed 
quantitatively through meta-analyses. Irrespective of the degree of energy restriction 
administered (MER or VLED), isokinetic knee extensor strength showed significant 
decreases in response to diet-induced weight loss compared to baseline, whilst non-
significant decreases in handgrip strength compared to baseline were found with all 
types of diets combined. Due to significant heterogeneity in results, we quantitatively 
analysed the effect of an intervention involving MER or VLED on isokinetic knee 
extensor strength and handgrip strength. MER interventions resulted in significant 
decreases on isokinetic knee extensor strength and handgrip strength, whilst VLED 
intervention only resulted in a reduction in isokinetic knee extensor strength and no 
change in handgrip strength. In summation, these results show that dietary 
interventions prescribed for weight loss in overweight and obese populations may 
incur negative changes in muscle strength. However, in order to accurately compare 
changes in muscle strength in response to dietary interventions, there is a need to 
identify a standard technique to assess muscle strength as well as a group of muscles 
that are comparable across overweight and obese populations.  
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When comparing the effects of the degree of energy restriction on the parameters 
under examination in both meta-analyses described in Chapters 2 and 3, that is, bone 
and muscle strength respectively, mixed results were found. A total of 6 parameters 
were analysed quantitatively through meta-analyses; total hip BMD, lumbar spine 
BMD, total body BMD, osteocalcin, isokinetic knee extensor strength and handgrip 
strength. The significant results that were found with both MER and VLED 
interventions favoured negative changes on bone and muscle strength following 
dietary weight loss intervention. Those studies administering MER interventions 
revealed significant decreases in total hip BMD, isokinetic knee extensor strength and 
handgrip strength. A significant increase was found in the bone formation marker 
osteocalcin, indicating a change in bone homeostasis, and no significant changes were 
found with lumbar spine BMD and total body BMD when overweight and obese 
individuals were prescribed a MER intervention. Similarly, VLED interventions 
induced significant decreases in lumbar spine BMD and isokinetic knee extensor 
strength, but also induced a significant increase in total body BMD and no significant 
changes in total hip BMD, osteocalcin or handgrip strength. Taken together, these 
findings highlight that diet-induced weight loss, regardless of the type of dietary 
intervention prescribed, may contribute to negative changes in bone and muscle 
strength in an overweight and obese population. Thus, due to no clear delineation 
between which degree of energy restriction, MER or VLED, affects bone and muscle 
strength more detrimentally, there appears to be no reason not to prescribe fast weight 
loss interventions such as VLED over MER in terms of the potential adverse effects 
on bone or muscle strength. However, more research is needed in order to gain a 
clearer understanding as to the effects of varying energy restriction on bone and 
muscle strength, and this is currently being undertaken in two clinical trials in our 
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team: the PREVIEW Study Australia (PREVention of diabetes through lifestyle 
Intervention and population studies in Europe and around the World) and the TEMPO 
Diet Trial (Type of Energy Manipulation for Promoting optimum metabolic health 
and body composition in Obesity)(11, 12).  
 
4.1 Relationship between bone and muscle strength  
Although bone and muscle strength were examined independently in Chapters 2 and 
3, they do have a strong relationship with one another, with both organs being derived 
from a shared mesenchymal origin (13). Parallel changes occur in bone and muscle in 
response to exercise, disuse or aging (13). An example of the bone-muscle 
relationship is a study that prescribed resistance training to older men, which resulted 
in increases in both BMD and strength (14). Furthermore, in a clinical trial where the 
primary aim of the intervention was to increase BMD, muscle strength was found to 
concomitantly increase (15). Similarly, in another clinical trial that aimed to increase 
muscle strength as the primary outcome, BMD was also found to increase (16). In 
keeping with these findings, bone strength is proportional to muscle strength, due to 
its inherent mechanosensitive properties (17). Indeed, bone cells, in particular 
osteocytes, are specialized cells that are able to sense and subsequently respond to 
mechanical stimuli (18). The ‘mechanostat’ theory as proposed by Frost states that 
bone properties can be improved through high strain physical activity (19), and this 
would also increase muscle strength. These correlations are reflected in our findings, 
where diet-induced weight loss stimulated negative changes in BMD, bone turnover 
markers as well as decreases in muscle strength.  
 
4.1.1 Mechanisms contributing to bone loss 
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Mechanisms as to why bone loss may occur with weight loss have been proposed, 
relating to the changes in circulating concentrations of cytokines, hormones as well as 
the mechanical unloading effect of weight loss on bone. One such proposed 
mechanism is that with weight loss there is loss of fat mass, which results in a 
decrease in circulating concentrations of oestrogen (20, 21). Normally, oestrogen 
plays a protective role in bone integrity, by decreasing osteoclast differentiation and 
increasing factors that enhance osteoblastic maturation (22). Decreased levels of 
oestrogen, as seen in post-menopausal women, is known to contribute to bone loss 
through increased rates of bone resorption, via alterations in osteoblastic-osteoclastic 
homeostasis (23, 24). Thus, decreases in oestrogen that occur with diet-induced 
weight loss (21) may contribute to the decline in BMD. Another potentially 
contributing factor to the reduction in BMD with weight loss is the suppression of 
IGF-1 (25). Although there is little evidence to clarify whether decreases in IGF-1 
occurs with diet-induced weight loss in obese individuals, reductions in circulating 
IGF-1 with diet-induced weight loss have been shown in both rodents (26-28), and 
lean men and women (29). IGF-1 is normally responsible for the differentiation of 
osteoblasts (30), for the promotion of osteoblastic activity, that is the building of the 
bone matrix (22). For instance, with advancing age, growth hormone production by 
the pituitary gland is decreased, leading to a decrease in IGF-1 produced by the liver 
(22). This then has been shown to cause an imbalance in bone homeostasis with a 
decrease in the rate of bone formation and an increase in the rate of bone resorption 
(31, 32). Thus, despite a lack of substantial evidence of the effect of diet-induced 
weight loss in obese individuals on IGF-1, from the current information it could be 
suggested that a decrease in IGF-1 may occur. Therefore, diet-induced weight loss, 
like ageing (33), results in decreases in oestrogen (20, 21) and potential decreases in 
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circulating IGF-1 levels (34). As such, reductions in these hormones may contribute 
to the bone loss that occurs following dietary weight loss interventions.  
As foreshadowed, another factor that may influence the reduction of bone during 
energy restriction is the reduction in mechanical loading as a consequence of a 
reduction in body weight (3). Mechanical loading is an integral part of skeletal 
development as well as playing a role in increasing the strength of bone (35). 
Osteocytes are mechanosensing bone cells, which, when stimulated by a mechanical 
force, modulate the growth and maintenance of bone (35). When a mechanical load is 
placed on bone, the secretion by osteocytes of sclerostin, a protein that inhibits bone 
formation, is suppressed. However, when mechanical unloading occurs, sclerostin is 
secreted (35). Studies that have examined the changes in sclerostin levels in response 
to diet-induced weight loss or in states of unloading have found that sclerostin levels 
increase when patients are prescribed a dietary intervention without specific addition 
of, or supervision, of physical activity (35-37). Interestingly, a weight loss diet, when 
combined with both aerobic and resistance exercise, prevents the increase in 
circulating sclerostin levels otherwise associated with dietary restriction, suggesting a 
potential protective mechanism induced by exercise (36). Mechanical unloading 
differentially affects the two types of bone tissue (trabecular and cortical, as described 
in Chapter 1). That is, trabecular bone, due to its high turnover and metabolic activity 
(38, 39) appears to have a heightened sensitivity to mechanical unloading (40). This is 
relevant to this thesis, as the hip and spine bones both contain a high proportion of 
trabecular bone (2), which may explain why significant decreases in BMD were 
evident in the total hip and not total body BMD, as described in Chapter 2. Taken 
together, mechanical unloading and the resultant changes in sclerostin secretion seems 
to be a potential mechanism for the bone loss that occurs with diet-induced weight 
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loss, however more evidence is needed in order to determine a cause and effect 
relationship.  
 
4.1.2 Mechanisms contributing to muscle strength loss 
Like bone, muscle is affected by numerous neuroendocrine changes and physiological 
adaptations that occur with diet-induced weight loss. Muscle mass is associated with 
fat free mass, where a reduction in one is associated with a reduction in the other (41). 
For clarification, muscle mass is a subset of fat free mass that incorporates bone, 
extracellular fluids as well as non-bone fat free mass, including muscle, organs and 
connective tissue (42). This association has been shown in states of energy deficit, 
where both decreases in fat free mass and catabolism of skeletal muscle has been 
concurrently observed (43, 44). As a consequence of a loss of muscle mass, muscle 
strength also is reduced (45). Changes in the body’s neuroendocrine system during 
states of negative energy balance have been proposed to contribute to the loss of fat 
free mass (26). One particular neuroendocrine pathway that is affected by energy 
restriction is the hypothalamic-pituitary-gonadal axis, responsible for the body’s 
secretion of sex hormones such as oestrogen. A recent review has illustrated the 
beneficial influence of oestrogen on muscle strength (46). In post-menopausal women 
as well as in ovariectomized rodents, muscle strength was observed to be less 
compared to their oestrogen positive counterparts (46). Furthermore, a meta-analysis 
has found that muscle strength was greater in post-menopausal women on hormone 
replacement therapy than in those without treatment (47). However, the mechanism 
for the detrimental effect of oestrogen on muscle strength is unknown, with one study 
highlighting various potential factors including a decrease in motor units and an 
increase in oxidative stress markers that may lead to this observed outcome (48). As 
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mentioned above, circulating oestrogen concentrations have been shown to decrease 
in states of negative energy balance such as in diet-induced weight loss (21, 26), and 
therefore may contribute to the decreases in muscle strength revealed in Chapter 3. 
Additionally, as described earlier, during states of energy deficit, reductions in 
circulating IGF-1 concentrations, due to reduced activity of the somatotropic axis, 
have been noted, and this may confer reductions in muscle strength (26, 49). IGF-1 
has anabolic activity on muscle (50). It plays a central role in muscle protein 
synthesis, muscle cell activity and the proliferation of muscle progenitor cells, all of 
which influence muscle strength (22). In support of this, studies have found that in 
growth hormone deficient patients, and therefore IGF-1 deficient patients, muscle 
strength was reduced (51-53). Despite little evidence available surrounding changes in 
IGF-1 in obese individuals in response to diet-induced weight loss as mentioned 
previously, present data suggests that low levels of circulating IGF-1, or greater 
circulating concentrations of IGF-1 binding proteins – which bind IGF-1 and thereby 
reduce the amount of bioactive IGF-1 available (29, 54, 55) – occurs with weight loss 
(21). A decrease in bioavailability of IGF-1 results in reductions in the anabolic 
activity of muscle as well as reductions in the proliferation of myoblasts, all of which 
probably decrease muscle strength (56). Thus, hormonal changes in oestrogen and 
IGF-1 exerted on muscle appear to negatively affect bone integrity and can also 
negatively affect muscle function.  
 
Another point of consideration, as explored with bone, is the effect of mechanical 
unloading on muscle. Muscle is a highly plastic tissue that is able to alter its structure 
according to changing functional requirements (50). Normally, physical activity or 
increased mechanical load results in anabolic effects on muscle by inducing muscle 
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hypertrophy or an increase in muscle mass (13, 50). Therefore, the contrary occurs, 
that is, reducing the normal weight bearing load or decreasing the amount of physical 
activity has been shown to induce muscle atrophy and cause a reduction in muscle 
mass (40, 50, 57, 58). Studies conducted in rodents undergoing mechanical unloading 
through hind-limb suspension (40, 57), as well as in studies on humans in simulated 
space flight or microgravity (59, 60), showed that these interventions induced weight 
loss with associated reductions in muscle mass and muscle strength. A proposed 
explanation for the decrease in muscle strength was a reduction in protein synthesis 
due to the decrease in mechanical force (40). The aim of diet-induced weight loss is a 
reduction of body weight. Decreasing the normal weight load of the body as 
mentioned above decreases muscle mass and strength. These negative shifts in muscle 
may be explained by the reduced protein synthesis as seen in rodents and humans 
during mechanical unloading (40, 57, 59, 60). Therefore, a reduction in normal weight 
bearing forces exerted on the body may be a contributing factor to the reduction in 
muscle strength with diet-induced weight loss.  
 
Bone and muscle are two organ systems that are intertwined and heavily influence the 
other, with changes occurring in muscle due to unloading forces preceding bone 
changes (13, 40). The interrelated properties of bone and muscle are highlighted by 
the overlap in mechanisms that cause reductions in BMD and strength, respectively. 
The relationship between bone and muscle is also seen in a clinical context. 
Sarcopenia has been thought to contribute to reductions in BMD, leading to the pre-
disease state of osteopenia (40). Moreover, it has been found that individuals with 
sarcopenia are more likely to also have the bone disease of osteoporosis (61). These 
implications have important clinical relevance to our overweight and obese 
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population undergoing diet-induced weight loss interventions. Low muscle strength is 
correlated with an increased risk of fractures (62) and therefore, if not only muscle 
strength but also BMD are reduced in individuals during dietary intervention, this 
could contribute to an increase in the incidence of fractures and osteoporosis. Indeed, 
studies have found that weight loss, whether intentional or unintentional, is associated 
with significant increases in the risk of a hip fracture (63, 64). In the meta-analysis 
looking at the effect of weight loss on bone in Chapter 2, the decrease in BMD 
corresponded to an estimated 10-15% increase in fracture risk, with the maximum 
duration of dietary intervention administered equaling 24 months. Therefore, the 
findings from other studies as well as from the current meta-analyses suggest that 
there may be a need for dietary weight loss interventions to include muscle-
strengthening exercises, due to the known anabolic effects of exercise on bone and 
muscle (13).  
 
4.2 Effect of exercise on bone and muscle strength 
The particular exercise regime of exercise that produces the greatest yields for both 
bone and muscle strength has yet to be determined, however resistance training has 
shown to be preferable for both bone and muscle strength. Muscle strengthening 
exercises have been shown to promote the development and maintenance of healthy 
bone matter (65). Meta-analyses examining the effect of different exercise protocols 
on BMD have been conducted in post-menopausal women (66, 67) and in pre-
menopausal women (68). All meta-analyses (66-68) conclusively reported that 
resistance training lasting 12 months has significant impacts on preserving BMD 
compared to other forms of exercise, including jogging mixed with walking or stair 
climbing or agility exercises. Moreover, studies have found that resistance training 
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without the addition of aerobic exercise results in a more significant increase in 
muscle strength than when a combination of resistance and aerobic training are used 
(69-71). Muscle adapts differently according to the type of physical activity being 
undertaken. Resistance training induces an increase in muscle strength and muscle 
hypertrophy (72, 73), whilst aerobic or endurance regimes result in an increase in the 
muscle content of mitochondria, thereby increasing its maximal oxygen uptake ability 
(71, 74). A justification for why resistance training alone exerts greater benefits on 
muscle strength compared with protocols that encompass the same level of resistance 
training, but with the addition of aerobic training, is that aerobic exercise is thought to 
interfere or antagonize further increases in strength, due to changes in neural 
mechanisms or attenuation of muscle hypertrophy (75-77). However, a meta-analysis 
would be required to investigate the true overall effect of varying exercise modalities 
on both bone and muscle.  
 
4.3 Effect of weight regain on bone 
Overweight and obese individuals often will attempt to lose weight multiple times 
over the course of many years, with these periods of dietary restriction usually 
followed by weight regain (78, 79). During diet-induced weight loss, 6-month 
interventions resulted in a loss of BMD from the hip or lumbar spine (80, 81). When 
weight was measured at 12- and 18-month time points, weight regain had occurred 
but BMD regains had not (80, 81). Therefore, weight cycling – weight loss followed 
by regain, occurring 1 or more times – places a detrimental risk on bone, with this 
being an additive risk in those people who are inactive, or in post-menopausal women 
(78, 79). A large population-based study of 20,745 females and males over 15 years 
of age (82) demonstrated that females who lost 11 kg or more, or who recalled having 
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dieted over 11 times during their life, had an adjusted hazard ratio of 1.48 (95% 
confidence interval: 1.13-1.94) and 1.73 (1.11-2.68) for osteoporotic fractures, 
respectively (82). These findings suggest that the loss in BMD that occurs with 
weight loss both in a single diet-induced weight loss attempt, or several weight loss 
attempts, has a negative impact on the integrity of bone and thus measures need to be 
taken to ensure that the benefits of diet-induced weight loss outweigh any potential 
negative side effects.  
 
 
4.4 Future directions 
From the two studies presented, future research into the effect of diet-induced weight 
loss on the body should implement exercise regimes in order to find the optimal 
intervention for not only reducing obesity, but also preventing other areas of the body 
from deteriorating as a by-product. Given the numerous other benefits of physical 
activity (83), clinicians should recommend exercise regimes in conjunction with 
dietary interventions to curb the potential of a concomitant decrease in bone and 
muscle strength. The guidelines for preventing osteoporosis from the Australian 
Medical Association already suggest an exercise regime should be implemented in 
general (84). Stronger suggestions to include exercise in a weight loss regime should 
be made, especially to any aged cohorts due to the early onset of muscle deterioration 
from the age of 40 onwards (85), and because bone begins to decline (86, 87) by the 
age of 30, as part of the natural aging process.  
 
Another direction for future research is to determine the potential impact that this loss 
of bone and muscle strength with diet-induced weight loss could have on long term 
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health, and how this compares to the long term known metabolic benefits of weight 
loss. The studies in both Chapter 2 and 3 highlighted the negative changes that occur 
with diet-induced weight loss on bone and muscle strength respectively, in the short 
term. Future investigations are paramount in order to crystalize gaps in the literature 
surrounding whether weight loss causes permanent negative long-term effects on 
bone and muscle strength, or whether these changes dissipate with time. As alluded to 
in Chapter 2, only a handful of studies have measured BMD at time point beyond the 
completion of the dietary intervention. In those studies with a follow up time point, 
decreases in BMD of the total hip (88-90), lumbar spine (88, 91, 92) and total body 
(88, 92-95) were still evident 3 to 21 months after the conclusion of the diet-induced 
weight loss intervention. Fewer studies examining the affect of diet-induced weight 
loss on muscle strength had a follow up time point (90, 96-98), and in those studies 
that did investigate muscle strength at follow up, inconsistent results were found. 
Despite these potentially harmful adverse affects that may eventuate with diet-
induced weight loss, a meta-analysis has found that in the long term, weight loss has a 
positive impact on all-cause mortality relating to improvements in peak VO2, blood 
pressure, glucose and circulating concentrations of interleukin-6 (99), which is a pro-
inflammatory marker (100). Exactly when the benefits of weight loss for all-cause 
mortality manifest themselves is yet to be determined, with some studies noting 
benefits 4-5 years post intervention (101, 102), whilst others noticed improvements 
throughout the course of the post-intervention follow up period (103). As such, not 
only should future research be aimed at identifying what interventions are optimal for 
both promoting weight loss without excessive loss of bone or muscle strength, but 
long term studies are essential so that the benefits versus risks of weight loss can be 
clarified.  
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4.5 Conclusion 
In conclusion, from both meta-analyses presented in this thesis, the importance of 
combating the health problem of obesity through dietary interventions, including 
measures to prevent reductions in bone and muscle strength, has been highlighted. In 
brief, dietary interventions alone without exercise may potentially cause deleterious 
effects on the body. Thus, a holistic approach is needed when attempting to attenuate 
negative changes that occur in bone and muscle during diet-induced weight loss. 
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Supporting Information  
 
Supporting Methods 
The following example shows the specific key words (or MeSH terms) that were used for the search 
of MEDLINE for population, intervention and outcomes.  
 
Population 
1. exp overweight/ OR obesity/ OR obesity, abdominal/ OR obesity, morbid/ OR 
overweight.tw OR over weight.tw OR obes*.tw OR ((abdominal or subcutaneous or intra-
abdominal or visceral or retriperitoneal or retro peritoneal) adj3 fat*).tw 
 
Intervention 
2. diet/ OR diet*.tw OR diet, carbohydrate-restricted/ OR diet, fat-restricted/ OR diet, 
reducing/ OR diet, protein-restricted/ OR caloric restriction/ OR calor* restrict*.tw OR diet 
therapy/ OR weight loss/ OR weight los*.tw OR (weight adj5 (los* or reduc* or control* or 
decreas*)).tw OR ((low* or reduc* or restric*) adj3 (calori* or energy or protein or carb* or 
fat*)).tw 
 
Outcomes 
Bone mineral density/homeostasis 
3. (“Bone and Bones”/ AND homeostasis/) OR bone homeostasis.tw OR bone mass.tw OR 
bone turnover marker*.tw OR bone density/ OR (bone mineral adj3 density.tw OR BMD.tw 
OR (bone* adj2 (los* or degrade* or deminerali*)).tw OR (bone density adj2 (reduc* or 
decreas*)).tw OR bone resorption/ OR bone resorption.tw OR osteolysis/ or osteolysis.tw 
OR bone remodeling/ OR bone remodel?ing OR bone strength.tw 
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Bone markers  
4. (Procollagen type 1 adj3 propeptide).mp OR (Procollagen type I adj3 propeptide).mp OR 
P1NP.mp  OR osteocalcin/ OR osteocalcin.mp OR (C-telopeptide adj3 type-1 collagen).mp 
OR (C-telopeptide adj3 type-I collagen).mp OR CTX.mp OR CTX1.mp OR CTXI.mp OR 
sCTX.mp OR OR (N-telopeptide adj3 type 1 collagen).mp OR (N-telopeptide adj3 type I 
collagen).mp OR NTX.mp or sNTX.mp. 
 
Our final input command was population AND intervention AND outcome (bone mineral 
density/homeostasis OR bone markers). The example search strategy for MEDLINE (above) was 
adapted to suit each database. 
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Supporting Table 1. Study characteristics for interventions investigating bone mineral density (BMD) and serum or urinary concentrations of 
bone turnover markers. 
First author, 
year, 
reference 
Sample 
size 
Sex and 
menopausal status 
of participants 
(percent female) 
Age in 
years – 
mean ± 
SE and / 
or range 
Baseline 
BMI in 
kg/m2 – 
mean ± 
SE or 
range 
Duration of dietary 
weight loss intervention 
(additional time points 
reported and used in 
this review)  
Details of dietary 
weight loss 
intervention 
Baseline weight (and 
weight change from 
baseline at end of 
intervention) in kg – 
mean ± SE 
BMD outcome 
measurement 
sites relevant to 
this review 
(baseline mean 
± SE in g/cm2) 
Bone turnover 
outcome 
measurements 
relevant to this 
review, all measured 
in serum unless 
specified as urinary 
(baseline mean ± SE) 
Andersen 
(1997) (41) 
9 Women  38.1 ± 2.5 
 
33.6 ± 0.6 6 months LED for the first 20 
weeks, then MER for 
the final 4 weeks 
 
91.3 ± 3.0 (-19.4 ± 
4.5) 
Lumbar spine 
(L2 – L4) (1.29 
± 0.07) 
Total body (1.22 
± 0.03) 
 
Avenell 
(1994) (25) 
16 Women – post-
menopausal  
60.1 ± 1.3 31.4 ± 0.8 6 months 
 
MER with a high 
fibre, low fat diet 
81.1 ± 2.3 (-2.8 ± 
2.4) 
Lumbar spine 
(L2 – L4) (0.97 
± 0.05) 
 
Bosy-
Westphal 
(2011) (20) 
72 
 
 
 
Men and women – 
pre-menopausal 
(76%) 
36.2 ± 0.7 34.6 ± 0.5 3 months 
 
 
 
LED  
 
 
103.5 ± 2.0 (- 9.2 ± 
0.5) 
 
 
Lumbar spine 
(region not 
specified) (1.07 
± 0.02) 
Total body (1.00 
± 0.01) 
 
Bowen (2004) 
(42) 
25 
 
Men and women 
(40%) 
45.7 ± 2.8 34.6 ± 4.2 3 months MER with a high 
dairy protein diet (K) 
98.5 ± 3.1 (-9.0 ± 
4.4) 
Total body (1.09 
± 0.02) 
 
 25 Men and women 
(60%) 
47.4 ± 3.4 32.2 ± 0.8 3 months MER with a high 
mixed protein diet 
(L) 
90.7 ± 2.8 (-9.3 ± 
3.9) 
 
Total body  
(1.09 ± 0.03) 
 
Campbell 
(2010) (26) 
15 Women – post-
menopausal  
60.0 ± 3.0 30.0 ± 0.9 3 months MER with a normal 
protein diet (M) 
80.0 ± 2.9 (-9.0 ± 
3.9) 
Total body (1.17 
± 0.03) 
 
 15 
 
Women – post-
menopausal 
51.0 ± 2.0 30.8 ± 1.1 3 months 
 
MER with a high 
protein diet (N) 
82.5 ± 4.2 (-8.2 ± 
5.8) 
 Total body 
(1.18 ± 0.03) 
 
 14 
 
Women – post-
menopausal 
59.0 ± 2.0 28.4 ± 0.9 9 weeks – included in 3 
month category 
MER with a high 
carbohydrate diet (O) 
 
75.9 ± 2.4 (-5.6 ± 
3.4) 
 
Total body (1.11 
± 0.03) 
Osteocalcin (1.3 ± 1.2 
nmol/L) 
Urinary NTX (33.0 ± 
4.2 nmol/L BCE / 
nmol/L creatine) 
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 15 
 
Women – post-
menopausal 
60.0 ± 2.0 29.1 ± 1.1 9 weeks – included in 3 
month category 
MER with a high 
chicken protein diet 
(P) 
 
76.2 ± 2.8 (-8.9 ± 
3.8) 
 
Total body (1.14 
± 0.02) 
Osteocalcin (1.1 ± 0.7 
nmol/L) 
Urinary NTX (45.1 ± 
4.2 nmol/L BCE / 
nmol/L creatine) 
 14 Women – post-
menopausal 
58.0 ± 2.0 30.1 ± 0.8 9 weeks – included in 3 
month category 
MER with a high 
beef protein diet (Q) 
 
 
81.0 ± 2.5 (-6.6 ± 
3.6) 
Total body (1.14 
± 0.03) 
Osteocalcin (1.3 ± 1.5 
nmol/L) 
Urinary NTX (36.5 ± 
4.3 nmol/L BCE / 
nmol/L creatine) 
Chao (2000)  
(40) 
27 Women – post-
menopausal 
66.3 ± 1.1 
60 – 80 
≥ 27.3 12 months 
(6 months) 
MER 81.6 ± 2.0 (-7.7 ± 
2.0) 
Lumbar spine  
(L2 – L4) (1.02 
± 0.03) 
Total body (1.10 
± 0.02) 
Osteocalcin (3.9 ± 0.3 
nmol/L) 
Urinary NTX (32.6 ± 
5.6 nmol/L BCE / 
nmol/L creatine) 
Cifuentes 
(2004) (80) 
16 Women – post-
menopausal 
62.3 ± 1.3 27.3 ± 0.4 6 weeks – included in 2 
month category 
MER 74.5 ± 1.8 (-3.3 ± 
2.5) 
 Osteocalcin (3.0 ± 0.2 
nmol/L) 
NTX (10.8 ± 0.8 
nmol/L BCE ) 
Clifton (2008) 
(43) 
51 Women  20 – 65 27.0 – 40.0 12 months MER with a high 
protein diet (R) 
87.5 ± 1.7 (-5.7 ± 
2.4) 
Total body (1.02 
± 0.02) 
 
 48 Women 20 – 65 27.0 – 40.0 12 months 
 
MER with high 
carbohydrate diet (S) 
86.2 ± 1.8 (-5.7 ± 
2.6) 
Total body (1.02 
± 0.02) 
 
Compston 
(1992) (27) 
13 Women 47.2 ± 1.6 32.2 3 months VLED 93.6 ± 3.2 (-15.6 ± 
4.2) 
Total body (1.21 
± 0.02) 
 
Fogelholm 
(2001) (28) 
74 
 
 
 
Women – pre-
menopausal 
40.0 ± 0.5 34.0 ± 0.3 3 months 
 
 
 
VLED (I)  
 
92.0 ± 1.1 (-13.2 ± 
0.4) 
 
 
 
Lumbar spine  
(L2 – L4) (1.13 
± 0.01) 
Total body (1.12 
± 0.01) 
 
 28 Women – pre-
menopausal 
39.7 ± 0.6 ≥ 30  3 months MER (J) 93.2 ± 1.6 (-13.5 ± 
2.4) 
Lumbar spine  
(L2 – L4) (1.14 
± 0.02) 
Total body (1.12 
± 0.01) 
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Foster (2010) 
(29) 
154 
 
  
Men and women 
(68%) 
44.9 ± 0.8 36.1 ± 0.3 24 months 
(6 months,  
12 months) 
MER with low fat 
diet (E) 
103.5 ± 1.2 (-7.4 ± 
0.9) 
Total hip (1.10 
± 0.01) 
Lumbar spine  
(L1 – L4) (1.10 
± 0.01) 
 
 153 
 
Men and women 
(67%) 
46.2 ± 0.7 36.1 ± 0.3 24 months 
(6 months, 
12 months) 
MER with a low 
carbohydrate diet (F) 
103.3 ± 1.3 (-6.3 ± 
0.9) 
 
Total hip (1.10 
± 0.01) 
Lumbar spine  
(L1 – L4) (1.10 
± 0.01) 
 
Gossain 
(1999) (30) 
11 Women    6 months VLED  103.8 ± 4.8 (-20.6 ± 
6.0) 
Total hip (0.87 
± 0.02) 
Lumbar spine  
(L1 – L4) (1.02 
± 0.04) 
Total body (1.12 
± 0.02) 
 
Hamilton 
(2013) (23) 
115 Women – pre-
menopausal 
34.4 ± 0.6 28.2 ± 0.1 6 months VLED  77.1 ± 0.6 (-12.1 ± 
0.9) 
Total hip (1.08 
± 0.02) 
 
Hendel (1996) 
(44) 
31 Men and women 
(81%) 
42.0 ± 1.8 37.1 ± 0.2 12 months MER 105.5 ± 2.8 (-10.6 ± 
1.2) 
Total body (1.11 
± 0.02) 
 
Hinton (2009) 
(71) 
37 Men and women 
(65%) 
50.7 ± 1.6 39.3 ± 0.9 3 months VLED 111.6 ± 2.9 (-21.5 ± 
3.8) 
 Osteocalcin (0.9 ± 0.4 
nmol/L) 
CTX (0.72 ± 0.02 
μg/L) 
Hinton (2010) 
(21) 
113 Men and women 
(57%) 
40.8 ± 0.9 
19 – 50 
34.3 ± 0.4 12 months MER 101.9 + 1.2 (-12.4 ± 
0.2) 
Total body (1.30 
± 0.00) 
 
Hosny (2012) 
(31) 
20 Women – pre-
menopausal 
35.2 ± 0.6 32.9 ± 0.3 3 months LED 77.1 ± 1.2 (-8.2 ± 
1.5) 
Total hip (0.96 
± 0.02) 
Lumbar spine  
(L2 – L4) (1.15 
± 0.02) 
 
Hyldstrup 
(1993) (75) 
(Data 
analysed 
qualitatively) 
24 
(44) 
Men and women 
(84%) 
20 – 53 38.8 ± 1.4 8 months  
(2 months) 
VLED (-29.7 ± 1.2)  Osteocalcin 
Jensen (2001) 
(105) 
27 Women 19 – 70 34.0 ± 1.0 3 months LED 93.8 ± 2.7 (-6.2 ± 
3.9) 
 Osteocalcin (1.3 ± 0.3 
nmol/L) 
Jesudason 164 Women – post- 40 – 70 34.0 ± 0.4 24 months  MER with a high 88.6 ± 1.1 (-9.0 ± - Total hip (0.99 Osteocalcin (0.6 ± 0.2 
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(2013) (32)  
 
menopausal (12 months) protein diet (G) 
 
 
 
2.0) 
 
 
 
± 0.01) 
Lumbar spine  
(L2 – L4) (1.17 
± 0.01) 
nmol/L) 
CTX (0.39 ± 0.02 
μg/L) 
 159 Women – post-
menopausal 
40 – 70 33.4 ± 0.4 24 months  
(12 months) 
MER with a normal 
protein diet (H) 
88.6 ± 1.1 (-10.3 ± 
2.1) 
Total hip (1.00 
± 0.01) 
Lumbar spine  
(L2 – L4) (1.19 
± 0.02) 
Osteocalcin (0.6 ± 0.2 
nmol/L) 
CTX (0.39 ± 0.01 
μg/L) 
Lucey (2008) 
(72) 
66 Men and women 
(64%) 
66.0 ± 0.6 30.0 ± 0.2 2 months MER 86.7 ± 1.0 (-4.4 ± 
0.3) 
 Osteocalcin (1.5 ± 0.2 
nmol/L) 
CTX (0.46 ± 0.03 
μg/L) 
Urinary NTX (41.9 ± 
3.5 nmol/L BCE / 
nmol/L creatine) 
Nakata (2008) 
(33)  
21 Women – pre-
menopausal 
40.3 ± 1.4 27.4 ± 0.6 3.5 months – included in 
3 month category 
MER 67.2 ± 2.1 (-6.2 ± 
1.1) 
Lumbar spine  
(L2 – L4) (1.60 
± 0.02) 
Total body (1.20 
± 0.01) 
Osteocalcin (1.8 ± 0.2 
nmol/L) 
Urinary NTX (35.2 ± 
3.0 nmol/L BCE / 
nmol/L creatine) 
Noakes 
(2005) (68) 
52 
 
Women 50 ± 1.4 32.0 ± 0.8 3 months MER with a high 
protein diet (T) 
87.0 ± 1.6 (-7.6 ± 
0.1) 
 Osteocalcin (1.2 ± 0.1 
nmol/L) 
 48 Women 49.0 ± 1.3 33.0 ± 0.6 3 months MER with a high 
carbohydrate diet (U) 
86.0 ± 1.7 (-6.9 ± 
0.1) 
 Osteocalcin (0.9 ± 0.1 
nmol/L) 
Ramsdale 
(1994) (34) 
45 Women – pre-
menopausal 
33.7 ± 1.0 25.6 ± 0.3 6 months MER 67.3 ± 1.0 (-3.3 ± 
1.4) 
Lumbar spine  
(L1 – L4) (1.22 
± 0.02) 
Total body (1.19 
± 0.02) 
 
Rector (2009) 
(81) 
11 Women – pre-
menopausal 
18 – 35 27.9 ± 0.8 6 weeks – included in 2 
months category 
LED 76.6 ± 2.7 (-3.9 ± 
7.9) 
 Osteocalcin (1.9 ± 1.6 
nmol/L) 
CTX (0.73 ± 0.09 
μg/L) 
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Redman 
(2008) (22) 
12 
 
Men and women 
(50%) 
39.0 ± 2.0 27.3 ± 0.5 6 months  
(3 months) 
MER (A) 
 
81.2 ± 3.3 (-8.4 ± 
4.5) 
 
Total hip (1.07 
± 0.06) 
Total body (1.15 
± 0.03)  
Osteocalcin (2.5 ± 1.0 
nmol/L) 
CTX (0.60 ± 0.40 
μg/L) 
NTX (24.7 ± 1.6 
nmol/L BCE) 
 11 Men and women 
(64%) 
39.0 ± 2.0 27.8 ± 0.5 6 months  
(3 months) 
LED (B) 81.1 ± 3.2 (-11.2 ± 
4.4) 
Total hip (0.98 
± 0.05) 
Total body (1.12 
± 0.02) 
 
Osteocalcin (2.4 ± 1.1 
nmol/L) 
CTX (0.50 ± 0.10 
μg/L) 
NTX (23.7 ± 1.7 
nmol/L BCE) 
Ricci (1998) 
(35) 
16 Women – post-
menopausal 
55.0 ± 2.1 
 
32.9 ± 1.1 6 months MER 88.2 ± 3.5 (0.3 ± 5.1) Total body (1.15 
± 0.02) 
Osteocalcin (0.7 ± 0.1 
nmol/L) 
Ricci (2001) 
(45) 
14 Women – post-
menopausal 
55.9 ± 1.5 32.7 ± 1.0 6 months MER 87.3 ± 2.6 (-8.2 ± 
3.8) 
Total body (1.16 
± 0.02) 
Osteocalcin (0.7 ± 0.1 
nmol/L) 
Riedt (2005) 
(36) 
24 Women – post-
menopausal 
61.6 ± 1.3 27.2 ± 0.4 6 months  MER 73.8 ± 1.4 (-7.3 ± 
2.0) 
Total body (1.12 
± 0.01) 
Osteocalcin (2.5 ± 0.2 
nmol/L) 
NTX (12.9 ± 1.0 
nmol/L BCE) 
Riedt (2007) 
(46) 
17 Women – pre-
menopausal 
24 – 49 27.7 ± 0.5 6 months MER 71.4 ± 1.6 (-4.7 ± 
2.2) 
Total hip (1.03 
± 0.02) 
Lumbar spine  
(L2 – L4) (1.20 
± 0.03) 
Total body (1.17 
± 0.02) 
Osteocalcin (1.3 ± 0.00 
nmol/L) 
NTX (14.6 ± 1.0 
nmol/L BCE) 
Shah (2011) 
(73) 
26 Men and women 
(65%) 
70.0 ± 0.8 37.2 ± 0.9 6 months MER 104.0 ± 2.9 (-9.0 ± 
1.1) 
 P1NP (41.5 ± 2.4 μg/L) 
Osteocalcin (2.0 ± 0.7 
nmol/L) 
CTX (0.31 ± 0.02 
μg/L) 
Shapses 
(2001) (47) 
14 Women – pre-
menopausal 
42.1 ± 0.8 
 
34.5 ± 1.0 6 months MER 93.8 ± 3.5 (-8.1 ± 
4.6) 
Lumbar spine  
(L2 – L4) (1.27 
± 0.02) 
Total body (1.21 
± 0.01) 
Osteocalcin (0.9 ± 0.1 
nmol/L) 
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Silverman 
(2009) (48) 
40 Women – post-
menopausal 
58.0 ± 0.8 32.4 ± 0.7 6 months MER 87.4 ± 2.3 (-6.4 ± 
3.3) 
Lumbar spine  
(L2 – L4) (1.12 
± 0.03) 
 
Sukumar 
(2011) (37) 
26 
 
 
 
 
Women – post-
menopausal 
58.5 ± 0.8 
 
32.1 ± 0.7 12 months  
(6 months) 
 
 
 
MER with a high 
protein diet (C) 
 
 
 
 
88.5 ± 3.0 (-5.7 ± 
4.2) 
 
 
 
 
Total hip (1.02 
± 0.02) 
Lumbar spine  
(L2 – L4) (1.24 
± 0.03) 
Total body (1.20 
± 0.02) 
P1NP (48.2 ± 3.2 μg/L) 
NTX (12.5 ± 0.7 
nmol/L BCE) 
 21 Women – post-
menopausal 
57.4 ± 1.0 32.1 ± 0.7 12 months 
(6 months) 
MER with a normal 
protein diet (D) 
82.7 ± 2.7 (-6.1 ± 
3.7) 
Total hip (0.94 
± 0.02) 
Lumbar spine  
(L2 – L4) (1.13 
± 0.04) 
Total body (1.14 
± 0.02) 
P1NP (56.6 ± 3.4 μg/L) 
NTX (13 ± 1.4 nmol/L 
BCE) 
Svendsen 
(1993) (49) 
(Data 
analysed 
qualitatively) 
51 Women 45 – 54 ≥ 25.0 3 months MER (-9.5 ± 0.4) 
 
Lumbar Spine  
Total body  
 
Osteocalcin 
Thorpe (2008) 
(24) (Data 
analysed 
qualitatively) 
64 Men and women 
(56%) 
45.5 30.9 12 months MER with a high 
protein diet 
Data not available  Total hip  
Lumbar spine  
(L1 – L4) 
Total body  
 
  Men and women 
(53%) 
47.0 31.9 12 months MER with a high 
carbohydrate diet 
Data not available  Total hip  
Lumbar spine  
(L1- L4) 
Total body  
 
Uusi-Rasi 
(2009) (70) 
26 
 
Women – pre-
menopausal 
43.1 ± 1.2 35.9 ± 2.6 3 months MER (V) 95.6 ± 4.9 (-2.0 ± 
5.1) 
 
 P1NP (33.3 ± 4.5 μg/L) 
CTX  (11.0 ± 2.4 
nmol/L) 
 11 Women – pre-
menopausal 
40.6 ± 2.4 34.0 ± 1.2 3 months VLED (W) 98.1 ± 3.7 (-9.5 ± 
6.6) 
 P1NP (36.6 ± 3.2 μg/L) 
CTX (10.2 ± 1.5 
nmol/L) 
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Uusi-Rasi 
(2010) (69) 
22 Women – pre-
menopausal 
41.4 ± 0.8 33.3 ± 0.7 3 months VLED with large 
weight loss (-19.2 to -
13.5% of body 
weight) (X) 
97.1 ± 3.2 (-14.5 ± 
4.4) 
 P1NP (40.1 ± 3.7 μg/L) 
CTX (13.6 ± 1.0 
nmol/L) 
 
 22 Women – pre-
menopausal 
40.2 ± 1.0 33.1 ± 1.0 3 months VLED with medium 
weight loss (-13.4 to -
8.23% of body 
weight) (Y) 
93.1 ± 3.6 (-9.5 ± 
5.1) 
 
 P1NP (33.0 ± 2.8 μg/L) 
CTX (13.4 ± 1.2 
nmol/L) 
 
 22 Women – pre-
menopausal 
37.7 ± 1.4 34.4 ± 1.20 3 months VLED with low 
weight loss (-8.21 to -
2.1% of body weight) 
(Z) 
88.6 ± 2.3 (-4.7 ± 
3.3) 
 
 P1NP (37.5 ± 3.2 μg/L) 
CTX (14.2 ± 1.3 
nmol/L) 
 
Van Loan 
(1998) (38) 
14 Women  25 – 42 32.9 ± 0.2 4 months – included in 3 
month category 
MER 89.7 ± 3.6 (-9.3 ± 
5.0) 
Total body (1.22 
± 0.02) 
 
Villareal 
(2011) (74) 
26 Men and women 
(65%) 
70.0 ± 0.8 37.2 ± 0.9 6 months MER 104.0 ± 2.9 (-9.0 ± 
1.1) 
Total hip (1.02 
± 0.03) 
Lumbar spine  
(L1 – L4) (1.12 
± 0.03) 
Total body (1.25 
± 0.03) 
 
Von Thun 
(2013) (39) 
22 Women – post-
menopausal 
60.7 ± 0.8 28.3 ± 0.4 6 months  MER 73.1 ± 1.5 (-7.6 ± 
2.0) 
Total body (1.11 
± 0.02) 
Osteocalcin (3.0 ± 1.3 
nmol/L) 
NTX (11.6 ± 1.8 
nmol/L BCE) 
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Supporting Figure 1. Flow diagram for the process of publication selection, inclusion and 
exclusion from this systematic review and meta-analysis.  
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Supporting Figure 2. Forest plot of change in lumbar spine BMD (bone mineral density) from 
baseline until the end of dietary weight loss interventions of varying durations. Mean weight 
changes (MWC) during the dietary interventions are recorded next to the corresponding duration, ± 
standard deviations. The letter in parentheses to the right of each study is used to distinguish 
different dietary interventions from the same publication, with details of all corresponding dietary 
interventions listed in Supporting Table 1. Plotted values (and the numbers at right) represent the 
absolute changes in lumbar spine BMD (in g/cm2), with 95% confidence intervals (CI) illustrated by 
the error bars (or the numbers in parentheses at right). Mean ± SE of lumbar spine BMD at baseline 
was 1.16 ± 0.03 g/cm2. I2 indicates the percentage of heterogeneity for the dietary interventions of 
each duration. 
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Supporting Figure 3. Forest plot of change in total body BMD (bone mineral density) from 
baseline until the end of dietary weight loss interventions of varying durations. Mean weight 
changes (MWC) during the dietary interventions are recorded next to the corresponding duration, ± 
standard deviations. The letter in parentheses to the right of each study is used to distinguish 
different dietary interventions from the same publication, with details of all corresponding dietary 
interventions listed in Supporting Table 1. Plotted values (and the numbers at right) represent the 
absolute changes in total body BMD (in g/cm2), with 95% confidence intervals (CI) illustrated by 
the error bars (or the numbers in parentheses at right). Mean ± SE of total body BMD at baseline 
was 1.17 ± 0.02 g/cm2. I2 indicates the percentage of heterogeneity for the dietary interventions of 
each duration.  
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Supporting Figure 4. Forest plot of change in serum N-terminal propeptide of type I 
procollagen (P1NP) from baseline until the end of dietary weight loss interventions of varying 
durations. Mean weight changes (MWC) during the dietary interventions are recorded next to the 
corresponding duration, ± standard deviations. The letter in parentheses to the right of each study is 
used to distinguish different dietary interventions from the same publication, with details of all 
corresponding dietary interventions listed in Supporting Table 1. Plotted values (and the numbers 
at right) represent the absolute changes in serum P1NP concentrations (in μg/L), with 95% 
confidence intervals (CI) illustrated by the error bars (or the numbers in parentheses at right). Mean 
± SE of serum P1NP concentrations at baseline was 40.8 ± 3.3 µg/L. I2 indicates the percentage of 
heterogeneity for the dietary interventions of each duration. 
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Supporting Figure 5. Forest plot of change in serum C-terminal telopeptide of type I collagen 
(CTX, in nmol/L) from baseline until the end of dietary weight loss interventions of varying 
durations. Mean weight changes (MWC) during the dietary interventions are recorded next to the 
corresponding duration, ± standard deviations. The letter in parentheses to the right of each study is 
used to distinguish different dietary interventions from the same publication, with details of all 
corresponding dietary interventions listed in Supporting Table 1. Plotted values (and the numbers 
at right) represent the absolute changes in serum CTX concentrations (in nmol/L), with 95% 
confidence intervals (CI) illustrated by the error bars (or the numbers in parentheses at right). Mean 
± SE of serum CTX concentrations at baseline was 12.5 ± 1.5 nmol/L. I2 indicates the percentage of 
heterogeneity for the dietary interventions of each duration. 
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Supporting Figure 6. Forest plot of change in serum C-terminal telopeptide of type I collagen 
(CTX, in μg/L) from baseline until the end of dietary weight loss interventions of varying 
durations. Mean weight changes (MWC) during the dietary interventions are recorded next to the 
corresponding duration, ± standard deviations. The letter in parentheses to the right of each study is 
used to distinguish different dietary interventions from the same publication, with details of all 
corresponding dietary interventions listed in Supporting Table 1. Plotted values (and the numbers 
at right) represent the absolute changes in serum CTX concentrations (in μg/L), with 95% 
confidence intervals (CI) illustrated by the error bars (or the numbers in parentheses at right). Mean 
± SE of serum CTX concentrations at baseline was 0.51 ± 0.09 µg/L. I2 indicates the percentage of 
heterogeneity for the dietary interventions of each duration. 
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Supporting Figure 7. Forest plot of change in serum N-terminal telopeptide of type I collagen 
(NTX) from baseline until the end of dietary weight loss interventions of varying durations. 
Mean weight changes (MWC) during the dietary interventions are recorded next to the 
corresponding duration, ± standard deviations. The letter in parentheses to the right of each study is 
used to distinguish different dietary interventions from the same publication, with details of all 
corresponding dietary interventions listed in Supporting Table 1. Plotted values (and the numbers 
at right) represent the absolute changes in serum NTX concentrations (in nmol/L bone collagen 
equivalents, BCE), with 95% confidence intervals (CI) illustrated by the error bars (or the numbers 
in parentheses at right). Mean ± SE of serum NTX concentrations at baseline was 15.5 ± 1.2 nmol/L 
BCE. I2 indicates the percentage of heterogeneity for the dietary interventions of each duration. 
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Supporting Figure 8. Forest plot of change in urinary N-terminal telopeptide of type I 
collagen (NTX) from baseline until the end of dietary weight loss interventions of varying 
durations. Mean weight changes (MWC) during the dietary interventions are recorded next to the 
corresponding duration, ± standard deviations. The letter in parentheses to the right of each study is 
used to distinguish different dietary interventions from the same publication, with details of all 
corresponding dietary interventions listed in Supporting Table 1. Plotted values (and the numbers 
at right) represent the absolute changes in urinary NTX concentrations (in nmol/L bone collagen 
equivalents (BCE) / nmol/L creatine), with 95% confidence intervals (CI) illustrated by the error 
bars (or the numbers in parentheses at right). Mean ± SE of urinary NTX concentrations at baseline 
was 37.4 ± 4.1 nmol/L BCE / nmol/L creatine. I2 indicates the percentage of heterogeneity for the 
dietary interventions of each duration. 
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List of Abbreviations 
ADP  Air displacement plethysmography 
BCE  Bone collagen equivalents 
BIA  Bioelectrical impedance analysis 
BMC  Bone mineral content 
BMD  Bone mineral density 
BMI  Body mass index  
CTX   C-terminal telopeptide of type I collagen 
DXA  Dual energy x-ray absorptiometry 
IGF-1  Insulin-like growth factor 1 
LED   Low energy diet 
MER  Moderate energy restriction 
NTX  N-terminal telopeptide of type I collagen 
P1NP  N-terminal propeptide of type I procollagen 
1RM   One repetition maximum  
8RM  Eight repetition maximum 
VLED  Very low energy diet  
 
